Body and Mind (BMMJ) 10-Q 23 Mar 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jan. 31, 2020	Mar. 23, 2020
Document And Entity Information
Entity Registrant Name	BODY & MIND INC.
Entity Central Index Key	0001715611
Document Type	10-Q
Document Period End Date	Jan. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--07-31
Is Entity's Reporting Status Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		101,853,217
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Interactive Data Current	Yes

Condensed Consolidated Interim

Condensed Consolidated Interim Balance Sheets - USD ($)	Jan. 31, 2020	Jul. 31, 2019
Current
Cash and cash equivalents	$ 3,374,079	$ 9,004,716
Amounts receivable	1,094,449	939,909
Interests receivable (Note 6)	63,000	27,000
Prepaids	869,614	227,843
Inventory (Note 5)	1,522,260	1,390,419
Total Current Assets	6,923,402	11,589,887
Convertible Loan Receivable (Note 6)	948,310	52,225
Investment in NMG Ohio LLC (Note 17)	3,573,314	3,465,902
Investment in and advances to GLDH (Note 18)	11,886,379	7,373,036
Other investments (Note 19)		255,980
Property and Equipment (Note 7)	4,676,499	2,694,500
Brand and Licenses	8,172,000	8,172,000
Goodwill	2,635,721	2,635,721
TOTAL ASSETS	38,815,625	36,239,251
Current
Accounts payables	941,736	979,384
Accrued liabilities	95,070	95,234
Income taxes	239,358	239,358
Due to related parties (Note 8)	7,680	12,952
Lease liabilities (Note 20)	195,983
Total Current Liabilities	1,479,827	1,326,928
Lease Liabilities (Note 20)	905,715
Deferred Tax Liability	1,716,120	1,716,120
TOTAL LIABILITIES	4,101,662	3,043,048
STOCKHOLDERS' EQUITY
Capital Stock- Statement 3 (Note 11) Authorized: 900,000,000 Common Shares - Par Value $0.0001 Issued and Outstanding: 101,853,217 (31 July 2019 - 97,279,891) CommonShares	10,185	9,728
Additional Paid-in Capital	45,285,374	41,765,408
Shares to be Issued (Notes 10, 11 and 14)	1,232,548	1,118,815
Other Comprehensive Income	843,067	827,314
Deficit	(12,657,211)	(10,525,062)
TOTAL STOCKHOLDERS' EQUITY	34,713,963	33,196,203
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 38,815,625	$ 36,239,251

Condensed Consolidated Interi_2

Condensed Consolidated Interim Balance Sheets (Parenthetical) - $ / shares	Jan. 31, 2020	Jul. 31, 2019
Statement of Financial Position [Abstract]
Common stock, shares authorized	900,000,000	900,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares outstanding	101,853,217	97,279,891
Common stock, shares issued	101,853,217	97,279,891

Condensed Consolidated Interi_3

Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Income Statement [Abstract]
Sales	$ 1,572,284	$ 1,195,745	$ 3,013,910	$ 2,521,723
Sales tax	(356,394)	(115,927)	(554,918)	(247,346)
Cost of sales	(686,691)	(575,948)	(1,609,664)	(1,313,569)
Total sales	529,199	503,870	849,328	960,808
General and Administrative Expenses
Accounting and legal (Note 8)	356,491	218,899	400,684	297,280
Bad debt expense	46,931		46,931
Consulting fees (Notes 8 and 16)	135,953	107,687	356,180	110,287
Depreciation	5,331	3,348	10,206	6,488
Insurance	22,605	16,538	51,330	38,776
Lease expense	54,926		111,630
Licenses, utilities and office administration	239,576	325,527	544,300	410,619
Management fees (Note 8)	55,683	114,430	185,261	167,274
Regulatory, filing and transfer agent fees	22,598	41,853	39,334	49,049
Rent	8,092	18,000	20,457	36,362
Salaries and wages	453,807	188,965	937,858	383,140
Stock-based compensation (Notes 8 and 11)	369,437	870,808	659,015	870,808
Travel	41,436	11,703	92,337	13,726
Total	(1,812,866)	(1,917,758)	(3,455,523)	(2,383,809)
Loss Before Other Income (Expenses)	(1,283,667)	(1,413,888)	(2,606,195)	(1,423,001)
Other Income (Expenses)
Foreign exchange, net	1,914	(24,393)	(81,006)	(95,949)
Interest expense	(131,850)	(202,065)	(131,850)	(202,017)
Interest income	278,688		556,688
Loss on settlement (Note 19)	(239,328)		(239,328)
Management fee income	36,000		54,000
Other income			125,000
Write-off of assets	(1,008)		(1,008)
Equity in earnings (losses) (Note 17)	103,899	(23,939)	191,550	(31,559)
Net Loss for the Period Before Income Tax	(1,235,352)	(1,664,285)	(2,132,149)	(1,752,526)
Income tax expense		(99,394)		(222,948)
Net Loss for the Period	(1,235,352)	(1,763,679)	(2,132,149)	(1,975,474)
Other Comprehensive Income (Loss)
Foreign currency translation adjustment	(103,440)	(120,725)	15,753	(26,314)
Comprehensive Loss for the Period	$ (1,338,792)	$ (1,884,404)	$ (2,116,396)	$ (2,001,788)
Loss per Share - Basic and Diluted (in dollars per share)	$ (0.01)	$ (0.03)	$ (0.02)	$ (0.03)
Weighted Average Number of Shares Outstanding (shares)	101,841,511	66,697,215	101,495,573	57,236,016

Condensed Consolidated Interi_4

Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Share Capital Common Shares	Additional paid-in capital	Shares to be issued	Subscriptions receivable	Other comprehensive income	Deficit	Total
Beginning Balance at Jul. 31, 2018	$ 4,778	$ 16,918,082	$ 103,267		$ 532,405	$ (6,772,311)	$ 10,786,221
Beginning Balance (in shares) at Jul. 31, 2018	47,774,817
Foreign currency translation adjustment					94,411		94,411
Loss for the period						(211,795)	(211,795)
Ending Balance at Oct. 31, 2018	$ 4,778	16,918,082	103,267		626,816	(6,984,106)	10,668,837
Ending Balance (in shares) at Oct. 31, 2018	47,774,817
Beginning Balance at Jul. 31, 2018	$ 4,778	16,918,082	103,267		532,405	(6,772,311)	10,786,221
Beginning Balance (in shares) at Jul. 31, 2018	47,774,817
Loss for the period							(1,975,474)
Ending Balance at Jan. 31, 2019	$ 7,263	26,779,252	75,939	$ (787,123)	506,091	(8,747,785)	17,833,637
Ending Balance (in shares) at Jan. 31, 2019	72,628,084
Beginning Balance at Jul. 31, 2018	$ 4,778	16,918,082	103,267		532,405	(6,772,311)	10,786,221
Beginning Balance (in shares) at Jul. 31, 2018	47,774,817
Ending Balance at Jul. 31, 2019	$ 9,728	41,765,408	1,118,815		827,314	(10,525,062)	33,196,203
Ending Balance (in shares) at Jul. 31, 2019	97,279,891
Beginning Balance at Oct. 31, 2018	$ 4,778	16,918,082	103,267		626,816	(6,984,106)	10,668,837
Beginning Balance (in shares) at Oct. 31, 2018	47,774,817
Private placement (Note 10)	$ 1,600	4,882,240					4,883,840
Private placement (Note 10) (in shares)	16,000,000
Exercise of warrants (Note 11)	$ 321	1,204,875					1,205,196
Exercise of warrants (Note 11) (in shares)	3,206,160
Issuance of escrowed shares (Note 10)	$ 7	27,321	(27,328)
Issuance of escrowed shares (Note 10) (in shares)	70,500
Share issue costs	$ 31	(270,767)					(270,736)
Share issue costs (in shares)	322,581
Finance fee for promissory note (Note 8)	$ 111	822,383					822,494
Finance fee for promissory note (Note 8) (in shares)	1,105,083
Investment agreement with Australis (Note 15)	$ 177	786,946		(787,123)
Investment agreement with Australis (Note 15) (in shares)	1,768,545
Acquisition of NMG Ohio LLC (Note 16)	$ 238	1,448,567					1,448,805
Acquisition of NMG Ohio LLC (Note 16) (in shares)	2,380,398
Equity component of convertible debenture (Note 9)		88,797					88,797
Stock-based compensation (Notes 11)		870,808					870,808
Foreign currency translation adjustment					(120,725)		(120,725)
Loss for the period						(1,763,679)	(1,763,679)
Ending Balance at Jan. 31, 2019	$ 7,263	26,779,252	75,939	$ (787,123)	506,091	(8,747,785)	17,833,637
Ending Balance (in shares) at Jan. 31, 2019	72,628,084
Beginning Balance at Jul. 31, 2019	$ 9,728	41,765,408	1,118,815		827,314	(10,525,062)	33,196,203
Beginning Balance (in shares) at Jul. 31, 2019	97,279,891
Acquisition of GLDH (Note 18)	$ 434	2,752,348					2,752,782
Acquisition of GLDH (Note 18) (in shares)	4,337,111
Exercise of warrants (Note 11)	$ 14	75,535					75,549
Exercise of warrants (Note 11) (in shares)	143,230
Stock-based compensation (Notes 11)		289,578					289,578
Share subscriptions received in advance			15,291				15,291
Foreign currency translation adjustment					119,193		119,193
Loss for the period						(896,797)	(896,797)
Ending Balance at Oct. 31, 2019	$ 10,176	44,882,869	1,134,106		946,507	(11,421,859)	35,551,799
Ending Balance (in shares) at Oct. 31, 2019	101,760,232
Beginning Balance at Jul. 31, 2019	$ 9,728	41,765,408	1,118,815		827,314	(10,525,062)	33,196,203
Beginning Balance (in shares) at Jul. 31, 2019	97,279,891
Loss for the period							(2,132,149)
Ending Balance at Jan. 31, 2020	$ 10,185	45,285,374	1,232,548		843,067	(12,657,211)	34,713,963
Ending Balance (in shares) at Jan. 31, 2020	101,853,217
Beginning Balance at Oct. 31, 2019	$ 10,176	44,882,869	1,134,106		946,507	(11,421,859)	35,551,799
Beginning Balance (in shares) at Oct. 31, 2019	101,760,232
Exercise of warrants (Note 11)	$ 2	15,289					15,291
Exercise of warrants (Note 11) (in shares)	22,485
Escrow release	$ 7	17,779	(17,786)
Escrow release (in shares)	70,500
Stock-based compensation (Notes 11)		369,437					369,437
Share subscriptions received in advance			(15,291)				(15,291)
Accretion and interest on convertible debt			131,519				131,519
Foreign currency translation adjustment					(103,440)		(103,440)
Loss for the period						(1,235,352)	(1,235,352)
Ending Balance at Jan. 31, 2020	$ 10,185	$ 45,285,374	$ 1,232,548		$ 843,067	$ (12,657,211)	$ 34,713,963
Ending Balance (in shares) at Jan. 31, 2020	101,853,217

Condensed Consolidated Interi_5

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)	6 Months Ended
	Jan. 31, 2020USD ($)	Jan. 31, 2019USD ($)
Cash Resources Provided By (Used In) Operating Activities
Loss for the period	$ (2,132,149)	$ (1,975,474)
Items not affecting cash:
Accrued interest and accretion	131,850	207,222
Accrued interest income	(520,000)
Accrued management fee income	(54,000)
Depreciation	157,855	141,901
Foreign exchange	35,786	2,386
Income tax		222,948
(Gain) or loss of equity investee	(191,550)	31,559
Loss on settlement	239,328
Stock-based compensation	659,015	870,808
Amounts receivable and prepaids	(716,996)	(125,748)
Inventory	(131,841)	(615,174)
Trade payables and accrued liabilities	(37,812)	369,957
Due to related parties	(5,272)	(45,489)
Net Cash Provided by (Used in) Operating Activities	(2,565,786)	(915,104)
Investing Activities
Repayment by (investment in) NMG Ohio, LLC	90,969	(612,619)
Investment in GLDH	(1,285,960)	(5,752,180)
Other investments	(334,348)
Purchase of property and equipment	(802,471)	(145,760)
Convertible loan receivable	(842,085)
Net Cash Used In Investing Activities	(3,173,895)	(6,510,559)
Financing Activities
Issuance of shares, net of share issue costs	90,840	5,818,300
Loans obtained		5,202,579
Loans repaid		(1,175,000)
Net Cash Provided by Financing Activities	90,840	9,845,879
Effect of exchange rate changes on cash	18,204	(26,314)
Net Increase (Decrease) in Cash	(5,630,637)	2,393,902
Cash-Beginning of Period	9,004,716	324,837
Cash-End of Period	$ 3,374,079	$ 2,718,739

Nature and Continuance of Opera

Nature and Continuance of Operations	6 Months Ended
	Jan. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature and Continuance of Operations	1. Nature and Continuance of Operations Body and Mind Inc. (the “Company”) was incorporated on 5 November 1998 in the State of Delaware, USA, under the name Concept Development Group, Inc. In May 2004, the Company acquired 100% of Vocalscape, Inc. and changed its name to Vocalscape, Inc. On October 28, 2005, the Company changed our name to Nevstar Precious Metals Inc. On October 23, 2008, the Company changed its name to Deploy Technologies Inc. (“Deploy Tech”) and, on September 15, 2010, the Company incorporated a wholly-owned subsidiary, Deploy Acquisition Corp. (“Deploy”) under the laws of the State of Nevada, USA. On September 17, 2010, the Company merged with and into Deploy under the laws of the State of Nevada. Deploy, as the surviving corporation of the merger, assumed all the assets, obligations and commitments of Deploy Tech, and we were effectively re-domiciled in the State of Nevada. Upon the completion of the merger, Deploy assumed the name “Deploy Technologies Inc.”, and all of the issued and outstanding common stock of Deploy Tech was automatically converted into and became Deploy’s issued and outstanding common stock. On 14 November 2017, the Company acquired Nevada Medical Group, LLC (“NMG”) and changed its name to Body and Mind Inc. The Company is now a supplier and grower of medical and recreational cannabis in the state of Nevada, and has retail operations in California, Ohio and Arkansas. These unaudited condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These unaudited condensed consolidated interim financial statements do not include all information and footnotes required by GAAP for complete financial statements. Except as disclosed herein, there have been no material changes in the information disclosed in the notes to the financial statements for the year ended 31 July 2019. The unaudited condensed consolidated interim financial statements should be read in conjunction with the Company’s audited financial statements for the year ended 31 July 2019. In the opinion of management, all adjustments considered necessary for fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the six months ended 31 January 2020 are not necessarily indicative of the results that may be expected for the year ending 31 July 2020. Principles of Consolidation These consolidated financial statements include the financial statements of the Company and its subsidiaries as follows: Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100% 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100% 14 November 2017 NMG Retail LLC Nevada, USA 75% 14 September 2018 NMG Long Beach LLC California, USA 100% 18 December 2018 NMG Cathedral City LLC California, USA 100% 4 January 2019 NMG Chula Vista LLC California, USA 51% 10 January 2019 NMG San Diego LLC California, USA 60% 30 January 2019 All inter-company transactions and balances are eliminated upon consolidation. These consolidated financial statements include the following investments accounted for using the equity method of accounting: Name Jurisdiction Ownership Date of acquisition or formation NMG Ohio LLC Ohio, USA 30% 27 April 2017

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jan. 31, 2020
Accounting Policies [Abstract]
Recent Accounting Pronouncements	2. Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13 “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. ASU 2016-13 is effective for annual reporting periods, and interim periods within those years beginning after 15 December 2019. The Company does not anticipate this amendment to have a significant impact on the financial statements. In August 2018, the FASB issued ASU 2018-13, Disclosure Framework –Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820). ASU 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. ASU 2018-13 is effective for annual and interim periods beginning after 15 December 2019. Early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements. The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jan. 31, 2020
Accounting Policies [Abstract]
Significant Accounting Policies	3. Significant Accounting Policies The following is a summary of significant accounting policies used in the preparation of these condensed consolidated interim financial statements. Basis of presentation These condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July. Cash and cash equivalents Cash and cash equivalents include highly liquid investments with original maturities of three months or less. Amounts receivable Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As at 31 January 2020 and 31 July 2019, the Company has no allowance for doubtful accounts. Revenue recognition During the year ended 31 July 2018, the Company recognized revenue in accordance with ASC 605, “Revenue Recognition”. Revenue was considered realized or realizable and earned when all of the following criteria were met: (1) persuasive evidence of an arrangement exists, (2) the sales price is fixed or determinable, (3) collectability is reasonably assured, and (4) products have been shipped and the customer has taken ownership and assumed risk of loss. On 1 August 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers” and all of the related amendments, which are also codified into ASC 606. The Company elected to adopt this guidance using the modified retrospective method. The adoption of this guidance did not have a material effect on the Company’s financial position, results of operations or cash flows. Under the new standard, the Company recognizes a sale as follows: The Company recognizes revenue product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement. Upon transfer of control, the Company has no further performance obligations. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration. Inventory Inventory consists of raw material, work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its raw material, finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost. The Company periodically reviews its inventory for obsolete and potentially impaired items. As at 31 January 2020 and 31 July 2019, the Company has no reserve for inventory. Property and equipment Property and equipment are stated at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of 15 years or the term of the lease Brands and licenses Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses have indefinite lives; therefore no amortization is recognized. Income taxes Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. Basic and diluted net loss per share The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Comprehensive loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the condensed consolidated interim financial statements. As at 31 January 2020 and 31 July 2019, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements. Foreign currency translation The Company’s functional currency is the Canadian dollar and its reporting currency is the U.S. dollars. The Company’s subsidiaries have a functional currency of U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of income. Stock-based compensation The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur. Fair value measurements The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. Other current financial assets and current financial liabilities have fair values that approximate their carrying values. Use of estimates and assumptions The preparation of condensed consolidated interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates. Lease accounting Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that do not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment. Comparative figures Certain comparative figures have been adjusted to conform to the current year’s presentation.

Financial Instruments

Financial Instruments	6 Months Ended
	Jan. 31, 2020
Investments, All Other Investments [Abstract]
Financial Instruments	4. Financial Instruments The following table represents the Company’s assets that are measured at fair value as of 31 January 2020 and 31 July 2019: As at 31 January 2020 As at 31 July 2019 Financial assets at fair value Cash $ 3,374,079 $ 9,004,716 Convertible loan receivable 948,310 52,225 Total financial assets at fair value $ 4,322,389 $ 9,056,941 Management of financial risks The financial risk arising from the Company’s operations include credit risk, liquidity risk, interest rate risk and currency risk. These risks arise from the normal course of operations and all transactions undertaken are to support the Company’s ability to continue as a going concern. The risks associated with these financial instruments and the policies on how to mitigate these risks are set out below. Management manages and monitors these exposures to ensure appropriate measures are implemented on a timely and effective manner. Credit risk Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company is not exposed to credit risk related to cash and cash equivalents as it does not hold cash in excess of federally insured limits, with major financial institutions. Credit risk associated with the convertible loans receivable (including the investment in and advances to Green Light District Holdings, Inc.) arises from the possibility that the principal and/or interest due may become uncollectible. The Company mitigates this risk by managing and monitoring the underlying business relationship. Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company ensures, as far as reasonably possible, that it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company’s holdings of cash. The Company has an accumulated deficit of $12,657,211, recurring losses of $2,132,149 and negative cash flows from operations of $ for the six months ended 31 January 2020, and had a working capital of $5,443,575 as at 31 January 2020. There can be no assurance that the Company will be successful with generating and maintaining profitable operations or will be able to secure future debt or equity financing for its working capital and expansion activities. Interest rate risk Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as it does not hold financial instruments that will fluctuate in value due to changes in interest rates. Currency risk Currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company is exposed to currency risk by incurring expenditures and holding assets denominated in currencies other than its functional currency. Assuming all other variables remain constant, a 1% change in the Canadian dollar against the US dollar would not result in a significant change to the Company’s consolidated statement of operations.

Inventory

Inventory	6 Months Ended
	Jan. 31, 2020
Inventory Disclosure [Abstract]
Inventory	5. Inventory 31 January 2020 31 July 2019 Work in progress $ 233,818 $ 208,417 Finished goods 652,121 615,108 Consumables 636,321 566,894 Total $ 1,522,260 $ 1,390,419

Convertible loan receivable

Convertible loan receivable	6 Months Ended
	Jan. 31, 2020
Notes to Financial Statements
Convertible loan receivable	6 . Convertible loan receivable Effective March 15, 2019, the Company, through its wholly owned subsidiaries, DEP Nevada and NMG, entered into a convertible loan agreement and a management agreement with Comprehensive Care Group LLC (“CCG”), an Arkansas limited liability company, with respect to the development of a medical cannabis dispensary facility in West Memphis, Arkansas. Pursuant to the management agreement, NMG will provide operations and management services, including management, staffing, operations, administration, oversight, and other related services. Under the management agreement, NMG will be required to obtain approval from CCG for any key decisions as defined in the agreement and accordingly the Company does not control CCG. NMG will be paid a monthly management fee equal to 66.67% $6,000 The convertible loan agreement is for an amount up to $1,250,000 $6,000 40% The Company evaluated the convertible loan receivable’s settlement provisions and elected the fair value option in accordance with ASC 825 “Financial Instruments”, to value this instrument. Under such election, the loan receivable is measured initially and subsequently at fair value, with any changes in the fair value of the instrument being recorded in the consolidated financial statements as a change in fair value of the financial instruments. The Company estimates the fair value of this instrument by first estimating the fair value of the straight debt portion, excluding the embedded conversion option, using a discounted cash flow model. The Company then estimates the fair value of the embedded conversion option using the Black-Scholes Option Pricing Model. The sum of these two valuations is the fair value of the loan receivable. Management believes that the accretion of the straight debt portion and embedded derivative related to the conversion option are not material. As at 31 January 2020, the Company had advanced $948,310 $52,225) $18,000 (2019 - $ Nil)

Property and Equipment

Property and Equipment	6 Months Ended
	Jan. 31, 2020
Notes to Financial Statements
Property and Equipment	7 . Property and Equipment Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Right-of-use Assets Total Cost: Balance, 31 July 2018 $ 24,586 $ 435,109 $ 261,957 $ 27,694 $ 38,717 $ 1,644 $ 1,993,928 $ — $ 2,783,635 Additions 7,491 28,647 36,004 23,414 — 528 272,078 — 368,162 Balance, 31 July 2019 32,077 463,756 297,961 51,108 38,717 2,172 2,266,006 — 3,151,797 Additions 40,869 — 247,762 9,022 — — 740,503 — 1,038,156 ASC 842 adoption (Notes 13 and 20) — — — — — — — 1,187,116 1,187,116 Balance, 31 January 2020 72,946 463,756 545,723 60,130 38,717 2,172 3,006,509 1,187,116 5,377,069 Accumulated Depreciation: Balance, 31 July 2018 3,177 41,169 25,446 2,554 5,500 228 89,663 — 167,737 Depreciation 5,119 73,597 44,547 4,546 7,751 358 153,642 — 289,560 Balance, 31 July 2019 8,296 114,766 69,993 7,100 13,251 586 243,305 — 457,297 Depreciation 4,276 38,132 24,188 4,253 3,907 200 82,899 — 157,855 Asset lease expense (Note 20) — — — — — — — 85,418 85,418 Balance, 31 January 2020 12,572 152,898 94,181 11,353 17,158 786 326,204 85,418 700,570 Net Book Value: As at 31 July 2018 21,409 393,940 236,511 25,140 33,217 1,416 1,904,265 — 2,615,898 As at 31 July 2019 23,781 348,990 227,968 44,008 25,466 1,586 2,022,701 — 2,694,500 As at 31 January 2020 $ 60,374 $ 310,858 $ 451,542 $ 48,777 $ 21,559 $ 1,386 $ 2,680,305 $ 1,101,698 $ 4,676,499

Related Party Balances and Tran

Related Party Balances and Transactions	6 Months Ended
	Jan. 31, 2020
Related Party Transactions [Abstract]
Related Party Balances and Transactions	8 . Related Party Balances and Transactions In addition to those disclosed elsewhere in these condensed consolidated interim financial statements, related party transactions paid/accrued for the three and six months ended 31 January 2020 and 2019 are as follows: For the three months ended 31 January 2020 For the three months ended 31 January 2019 For the six months ended 31 January 2020 For the six months ended 31 January 2019 A company controlled by the President and Interim Chief Executive Officer Management fees $ 37,511 $ — $ 79,378 $ — A company controlled by the Chief Financial Officer and a director Management fees Accounting fees 25,232 — — 11,611 47,900 — — 18,519 A company controlled by a former director and former President of NMG Management fees 8,333 66,992 16,666 100,646 A company controlled by the Corporate Secretary Management fees Consulting fees 25,322 1,552 7,476 — 30,989 3,103 18,990 — A company controlled by the former Chief Executive Officer and a former director Management fees — — 9,401 — $ 97,950 $ 86,079 $ 187,437 $ 138,155 Amounts owing to related parties as at 31 January 2020 and 31 July 2019 are as follows: a) As at 31 January 2020, the Company owed $7,680 (31 July 2019 - $7,825) to the Interim Chief Executive Officer of the Company and a company controlled by him. b) As at 31 January 2020, the Company owed $Nil(31 July 2019 - $5,127) to the Chief Financial Officer of the Company The above amounts owing to related parties are unsecured, non-interest bearing and are due on demand.

Notes Payable

Notes Payable	6 Months Ended
	Jan. 31, 2020
Notes to Financial Statements
Notes Payable	9. Notes Payable In connection with the investment of Green Light District Holdings, Inc. (“GLDH”) on 29 November 2018, the Company issued a promissory note in the amount of $4,000,000 to Australis Capital Inc. (“Australis”) (Notes 15 and 18). The promissory note bears interest at a rate of 15% per annum, is secured by the assets of the Company, matures in two years and requires semi-annual interest payments unless the Company elects to accrue the interest by adding it to the principal amount. The Company issued 1,105,083 common shares of the Company as a finance fee to Australis valued at $822,494 (Note 11). During the year ended 31 July 2019, the Company repaid the note in full. The Company also paid a prepayment penalty of $200,000 for repaying the note prior to the maturity date. During the three and six months ended 31 January 2020, the Company accrued interest and accretion expense of $Nil (2019 - $176,090) and $Nil (2019 - $176,090), respectively.

Convertible Debenture

Convertible Debenture	6 Months Ended
	Jan. 31, 2020
Notes to Financial Statements
Convertible Debenture	10 . Convertible Debenture In connection with an investment agreement with Australis on 30 October 2018 (Notes 11, 15 and 16), the Company issued an unsecured convertible debenture in the amount of $1,217,547 (CAD $1,600,000) 8% CAD$0.55 At the date of issue, a beneficial conversion feature of $88,797 (CAD$116,714) was recognized and the debt portion of the convertible debentures was recorded at a value of $1,128,750 (CAD$1,483,636). The value of the beneficial conversion feature was recorded in equity as additional paid-in capital. Subsequent to initial recognition, the debt has been amortized over the term of the debt using the effective interest rate method at a rate of 11.3% per annum. During the year ended 31 July 2019, the Company accrued interest and accretion expense of $98,392. $72,623 $88,821 2,909,091

Capital Stock

Capital Stock	6 Months Ended
	Jan. 31, 2020
Notes to Financial Statements
Capital Stock	11 . Capital Stock The Company’s authorized share capital comprises 900,000,000 Common Shares, with a $0.0001 par value per share. On 2 November 2018, the Company closed a non-brokered private placement of 16,000,000 units at a price of $0.30 (CAD$0.40) per unit for aggregate gross proceeds of $4,883,840 (CAD$6,400,000) (Note 10, 15 and 16). Each unit consists of one common share and one share purchase warrant. Each warrant entitles the holder to purchase one additional common share of the Company at a price of CAD$0.50 per warrant for a period of two years. The Company paid cash of $152,720 and issued 322,581 common shares valued at $221,691 as finders’ fees in relation to this private placement. On 29 November 2018, the Company issued 1,105,083 common shares as a finance fee to Australis valued at $822,494 (Note 9). On 30 November 2018, the Company issued 3,206,160 common shares upon exercise of 3,206,160 warrants by Australis at a price of CAD$0.50 per common share for aggregate proceeds of $1,205,196 (CAD$1,603,080). On 31 January 2019, the Company issued 1,768,545 common shares to Australis for proceeds of $787,123 pursuant to the Investment Agreement (Note 16). On 31 January 2019, the Company issued 2,380,398 common shares valued at $1,448,805 in relation to acquiring the remaining 70% of NMG Ohio LLC (Note 17). On 14 May 2019, the Company issued 70,500 previously escrowed shares with a fair value of $22,689 to Toro Pacific Management Inc. in connection with the acquisition of NMG (Note 14). On 17 May 2019, the Company closed a private placement of 11,780,904 units at a price of $0.93 (CAD$1.25) per unit for aggregate gross proceeds of $10,956,241 (CAD$14,726,130). Each unit is comprised of one common share and one common share purchase warrant. Each warrant entitles the holder to acquire one common share of the Company at an exercise price of CAD$1.50 for a period of 48 months following the closing date, subject to adjustment in certain events. The agents received a cash commission of $589,499 (CAD$793,938). The agents also received as additional consideration 635,150 non-transferable broker warrants. Each broker warrant entitles the holder to acquire one unit at an exercise price of CAD$1.25 per unit for a period of 48 months following the closing date. A corporate finance fee of $63,774 (CAD $84,750) was also paid. On 28 May 2019, the Company issued 12,793,840 common shares upon exercise of 12,793,840 warrants by Australis at a price of CAD$0.50 per common share for aggregate proceeds of $4,746,515 (CAD$6,396,920). The proceeds were used, in part, to fully repay the outstanding senior secured note in the amount of $4,495,890 owing to Australis by the Company (Note 9). On 16 July 2019, the Company issued 7,333 common shares upon exercise of 7,333 warrants at a price of CAD$0.90 per common share for aggregate proceeds of $5,057 (CAD$6,600). On 12 August 2019, the Company issued a total of 4,337,111 common shares of the Company in connection with the Purchase Agreement, NMG SD Settlement Agreement and the Lease Assignment Agreement (Notes 13 and 18). On 12 August 2019, the Company issued 81,591 common shares upon exercise of 81,591 warrants at a price of CAD$0.66 per common share for aggregate proceeds of $40,765 (CAD$53,850). On 12 September 2019, the Company issued 38,912 common shares upon exercise of 38,912 warrants at a price of CAD$0.66 per common share for aggregate proceeds of $19,450 (CAD$25,682). On 4 October 2019, the Company issued 22,727 common shares upon exercise of 22,727 warrants at a price of CAD$0.90 per common share for aggregate proceeds of $15,360 (CAD$20,454). On 14 November 2019, the Company issued 22,485 common shares upon exercise of 22,485 warrants at a price of CAD$0.90 per common share for aggregate proceeds of $15,291 (CAD$20,236). Stock options The Company previously approved an incentive stock option plan, pursuant to which the Company may grant stock options up to an aggregate of 10% of the issued and outstanding common shares in the capital of the Company from time to time. On 11 December 2018, the Company issued 2,050,000 stock options in accordance with the Company’s stock option plan at an exercise price of CAD$0.57 per share for a five year term expiring 10 December 2023. The options were granted to current directors, officers, employees and consultants of the Company. The fair value of the stock options was calculated to be $881,644 (CAD$1,165,117) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 5 years Expected volatility 265 % Expected dividend yield 0 % Risk-free interest rate 2.03 % On 21 August 2019, the Company issued 2,850,000 stock options with an exercise price of CAD$0.88 per share for a term of five years expiring on 21 August 2024. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. Prior to vesting, on 16 October 2019, the Company cancelled 400,000 stock options previously granted to a director due to forfeiture, which had not vested and on 23 January 2020, the Company cancelled 200,000 stock options previously granted to a director due to forfeiture, which had not vested The total fair value of the stock options granted was calculated to be $1,373,856 (CAD$1,818,232) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 5 years Expected volatility 140 % Expected dividend yield 0 % Risk-free interest rate 1.28 % During the three and six months ended 31 January 2020, the Company recorded a stock-based compensation of $327,879 (CAD$431,619) and $604,866 (CAD$798,398) related to these options, respectively. On 1 October 2019, the Company issued 250,000 stock options with an exercise price of CAD$0.93 per share for a term of five years expiring on 1 October 2024. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $145,045 (CAD$191,960) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 5 years Expected volatility 140 % Expected dividend yield 0 % Risk-free interest rate 1.37 % During the three and six months ended 31 January 2020, the Company recorded a stock-based compensation of $39,668 (CAD$52,316) and $52,259 (CAD$68,979) related to these options, respectively. On 23 January 2020, the Company issued 200,000 stock options with an exercise price of CAD$0.88 per share for a term of five years expiring on 23 January 2025. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $68,645 (CAD$90,608) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 5 years Expected volatility 140 % Expected dividend yield 0 % Risk-free interest rate 1.43 % During the three and six months ended 31 January 2020, the Company recorded a stock-based compensation of $1,890 (CAD$2,495) related to these options. Number of options Weighted average exercise price Weighted average contractual term remaining (in years) Aggregate intrinsic value Outstanding at 31 July 2018 4,025,000 CAD$0.65 4.34 CAD$ — Granted 2,050,000 CAD$0.57 Outstanding at 31 July 2019 6,075,000 CAD$0.62 3.69 CAD$1,675,750 Granted 3,300,000 CAD$0.88 Cancelled (600,000) CAD$0.88 Outstanding at 31 January 2020 8,775,000 CAD$0.70 3.624 CAD$ 1,750 Vested and fully exercisable at 31 January 2020 6,075,000 CAD$0.62 3.18 CAD$ 1,750 Share purchase warrants and brokers’ warrants Number of warrants Weighted average exercise price Outstanding at 31 July 2018 10,106,820 CAD$0.89 Issued 28,415,284 CAD$0.93 Exercised (16,007,333 ) CAD$0.50 Outstanding at 31 July 2019 22,514,771 CAD$1.22 Exercised (165,715 ) CAD$0.73 Expired (9,933,772 ) CAD$0.89 Outstanding at 31 January 2020 12,415,284 CAD$1.49 As at 31 January 2020, the following warrants are outstanding: Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$1.50 17 May 2023 635,150 CAD$1.25 16 May 2023 12,415,284

Segmented Information and Major

Segmented Information and Major Customers	6 Months Ended
	Jan. 31, 2020
Segment Reporting [Abstract]
Segmented Information and Major Customers	12. Segmented Information and Major Customers The Company’s activities are all in the one industry segment of medical and recreational cannabis. All of the Company’s revenue generating activities and capital assets relate to this segment and are located in the USA. During the six months ended 31 January 2020, the Company relied on one major customer for 10% of its revenues (31 January 2019 – no major customer over 10%) and as at 31 January 2020, the total amount due from this major customer is $123,667.

Supplemental Disclosures with R

Supplemental Disclosures with Respect to Cash Flows	6 Months Ended
	Jan. 31, 2020
Notes to Financial Statements
Supplemental Disclosures with Respect to Cash Flows	13 . Supplemental Disclosures with Respect to Cash Flows Three Month Period Ended 31 January Six Month Period Ended 31 January 2020 2019 2020 2019 Cash paid during the period for interest $ — $ — $ — $ — Cash paid during the period for income taxes $ — $ — $ — $ — On 30 November 2019, the Company entered into a Settlement Agreement with SD whereby the Company settled an aggregate receivable amount of $590,328 in exchange for $90,315 accounts receivable from future sale of Inventory, $25,000 future credit towards the Contribution Fee, and a production equipment valued at $235,685, resulting in a loss of $239,328 (Note 19). On 12 August 2019, the Company issued a total of 4,337,111 common shares of the Company in connection with the Purchase Agreement, NMG SD Settlement Agreement and the Lease Assignment Agreement valued at $2,752,782 (Notes 11 and 18). On adoption of ASC 842, Lease Accounting, the Company recognized right-of-use assets (Notes 7 and 20), and a corresponding increase in lease liabilities, in the amount of $1,187,116 which represented the present value of future lease payments using a discount rate of 12% per annum. In connection with the closing of the business combination transaction to acquire all of the issued and outstanding securities of NMG, the net proceeds of the Company’s private placements of certain subscription receipts was released to the Company from escrow in the amount of $17,786 (Note 14).

Business Acquisition

Business Acquisition	6 Months Ended
	Jan. 31, 2020
Business Combinations [Abstract]
Business Acquisition	14 . Business Acquisition On 15 May 2017, the Company entered into an assignment and novation agreement (the “Assignment Agreement”) with Toro Pacific Management Inc. (the “Transferor”) pursuant to which the Transferor assigned a letter of intent (the “LOI”) effective 12 May 2017 to the Company in accordance with its terms. The Assignment Agreement and the LOI contemplated a business combination transaction (the “Acquisition”) to acquire all of the issued and outstanding securities of NMG, an arm’s length Nevada-based licensed producer of medical cannabis. As consideration for the Assignment Agreement, the Company will issue to the Transferor 1,000,000 common shares of the Company. On 13 November 2017, the Assignment Agreement was amended, whereby the Company would issue the 1,000,000 common shares as follows: a. 470,000 common shares to Benjamin Rutledge upon closing of the Acquisition (issued); b. 60,000 common shares to Chris Hunt upon closing of the Acquisition (issued); c. 470,000 common shares to the Transferor according to the following schedule: · 1/10 of the Transferor’s shares upon closing of the Acquisition (issued); . 1/6 of the remaining Transferor’s shares 6 months after closing the Acquisition (issued); . 1/5 of the remaining Transferor’s shares 12 months after closing the Acquisition (issued); . 1/4 of the remaining Transferor’s shares 18 months after closing the Acquisition (issued); . 1/3 of the remaining Transferor’s shares 24 months after closing the Acquisition (issued); . 1/2 of the remaining Transferor’s shares 30 months after closing the Acquisition (issued); and . the remaining Transferor’s shares 36 months after closing the Acquisition. The remaining 423,000 135,202 Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. The Company’s brands and licenses have indefinite lives as long as the Company is in business. There are no indications of impairment as at 31 January 2020.

Commitments

Commitments	6 Months Ended
	Jan. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments	15 . Commitments a) In connection with the strategic investment agreement with Australis dated 30 October 2018 (the “Investment Agreement”) (Notes 10, 11 and 16), the Company agreed to pay a monthly service fee of $10,000 to Australis. In connection with the Company’s investment in GLDH and the promissory note provided by Australis (Note 9), the Company agreed to increase the monthly services fee to Australis to $16,500 per month for 5 years unless ownership held by Australis drops below 10% in which the fee will cease. Following the repayment of the promissory note, the monthly service fee to Australis was reduced to $12,000 commencing June 2019. b) On 25 October 2017, NMG Ohio entered into a five-year lease agreement for the property located at 709 Sugar Lane, Elyria, Ohio, containing approximately 4,100 square feet. The monthly rent is $4,200. c) On 13 June 2019, the five-year lease agreement dated 1 December 2018 for the property located at 7625 Carroll Road, San Diego, California, containing approximately 4,600 square feet was assigned to NMG San Diego. Under the terms of the assignment and first amendment to the original lease agreement dated 13 June 2019, the Company has three options to extend the lease and each option is for five years. The monthly base rent is currently $15,000. The guaranteed monthly rent is subject to a 1—6% increase on each anniversary date of the lease, based on increases in the Consumer Price Index for San Diego County. d) On 8 March 2019, the five-year lease agreement dated 10 January 2017, as amended on 7 September 2018, for the property located at 3411 E. Anaheim St., Long Beach, California, containing approximately 1,856 square feet was assigned to NMG Long Beach. Under the terms of the amended lease agreement, the Company has one option to extend the lease for five years. The monthly base rent is $6,636.40 plus common area expenses, totaling $8,000 every month. The guaranteed minimum monthly rent is subject to a 5% increase on each anniversary date of the lease. e) On 21 August 2019, the Company entered into new and updated management and consulting agreements with the following individuals: . President and the Interim Chief Executive Officer – $12,500 per month; . Chief Financial Officer – CAD$10,000 per month; . Chief Operating Officer – $15,000 per month; . Corporate Secretary – CAD$7,500 per month; . President of NMG and a director – $16,666 per month . Former Chief Executive Officer and an advisor - $12,500 per month.

Investment Agreement

Investment Agreement	6 Months Ended
	Jan. 31, 2020
Notes to Financial Statements
Investment Agreement	16 . Investment Agreement On 30 October 2018, the Company entered into the Investment Agreement with Australis. Pursuant to the terms of the Investment Agreement, Australis will acquire (i) 16,000,000 units of the Company (Note 11), and (ii) CAD$1,600,000 principal amount 8% unsecured convertible debentures (Note 10). Under the terms of the Investment Agreement, the parties agreed to negotiate in good faith a license agreement pursuant to which the Company will grant Australis an exclusive and assignable license to use the Body and Mind brand outside of the United States of America on commercially reasonable terms. In addition, the Company will enter into a commercial advisory agreement with Australis Capital (Nevada) Inc. (“Australis Nevada”), a wholly-owned subsidiary of Australis, pursuant to which Australis Nevada will provide advisory and consulting services to the Company at $10,000 per month for a term ending on the date that is the earlier of: (i) five years following the closing of the transactions contemplated by the Investment Agreement, and (ii) the date Australis no longer holds 10% or more of the issued and outstanding Common Shares (Note 15). Subject to certain exceptions, Australis will be entitled to maintain its’ pro rata interest in the Company until such time as it no longer holds 10% or more of the issued and outstanding Common Shares. Subject to applicable laws and the rules of the Canadian Securities Exchange (the “CSE”), for as long as Australis owns at least 10% of the issued and outstanding common shares, Australis will be entitled to nominate one director for election to the Board of Directors of the Company (the “Board”). If Australis exercises all of the warrants and converts all of the debentures purchased, Australis will be entitled to nominate a second director for election to the Board. On 2 November 2018, the Company executed the Investment Agreement and completed the sale of securities pursuant to the Investment Agreement. On 31 January 2019, the Company issued 1,768,545 common shares to Australis for proceeds of $787,123 pursuant to the Investment Agreement whereby the Company granted Australis anti-dilution participation rights to allow Australis to maintain a 35.783% ownership interest in the Company (Note 11). During the three and six months ended 31 January 2020, the Company paid an advisory fee of $36,000 (2019 - $43,000) and $72,000 (2019 - $43,000), respectively.

Investment in NMG Ohio LLC

Investment in NMG Ohio LLC	6 Months Ended
	Jan. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
Investment in NMG Ohio LLC	17. Investment in NMG Ohio LLC On 31 January 2019, the Company entered into a definitive agreement (“Definitive Agreement”) to acquire 100% ownership of NMG Ohio. The Company will purchase the remaining 70% interest for total cash payments of $1,575,000 and issuance of 3,173,864 common shares of the Company). As at 31 July 2019 the Company had issued 2,380,398 of the 3,173,864 common shares with a fair value of $1,448,805. During the year ended 31 July 2019, the Company made cash payments of $1,181,250. At 31 January 2020, the Definitive Agreement had not closed. The remaining cash payments totaling $393,750 and the remaining issuance of 793,466 common shares are expected to be paid and issued upon completion of the remaining Definitive Agreement closing items. Until such time as the Definitive Agreement closes, the Company will continue to account for its 30% ownership interest in NMG Ohio as an investment using the equity method of accounting. During the six months ended 31 January 2020, NMG Ohio recorded net revenues of $2,095,008, expenses of $1,456,508 and a net income of $638,500. The Company recorded an equity in earnings of $191,550 relating to its 30% pro rata share of net income which was included in other items on the statement of operations. 31 January 2020 31 July 2019 Opening balance $ 3,465,902 $ 77,600 Acquisition costs: Common shares issued to vendors at fair value — 1,448,805 Acquisition costs: Cash payments to vendors — 1,181,250 Dispensary build-out related costs 20,429 573,633 License fees — 100,000 Funds transferred 12,500 — Funds repaid (107,429 ) — Equity pickup 191,550 56,466 Foreign exchange (9,638 ) 28,148 Total $ 3,573,314 $ 3,465,902 Summarized financial information for NMG Ohio is as follows: 31 January 2020 Current assets $ 862,653 Non-current assets 877,993 Total assets 1,740,646 Current liabilities 921,657 Non-current liabilities — Total liabilities 921,657 Revenues 2,095,008 Gross profit 910,349 Net income 638,500 Net income attributable to the Company $ 191,550

Investment in and advances to G

Investment in and advances to GLDH	6 Months Ended
	Jan. 31, 2020
Investments [Abstract]
Investment in and advances to GLDH	18 Investment in and advances to GLDH Interim Agreement – 28 November 2018 On 28 November 2018, the Company entered into a binding interim agreement (the “Interim Agreement”) with GLDH, a private company incorporated under the laws of Delaware, and David Barakett (“Barakett”) whereby the Company agreed to acquire 100% of the issued and outstanding common shares of GLDH in connection with the issuance of convertible notes (the “Transaction”). GLDH holds a number of assets relating to the production and sale of cannabis products in the United States of America. The Transaction will be contingent upon the Company completing its due diligence. The terms of the Interim Agreement include the following: The Company shall issue to Barakett common shares of the Company (the “Earn Out Shares”) based on the CSE listed 5-day VWAP of the common shares of the Company and at the USD/CAD exchange rate at the close of market on 27 November 2018. The common shares of the Company had a 5-day VWAP of CAD$0.7439 at a USD/CAD exchange rate of 1.3296 and as a result the Company agreed to issue up to a maximum of 11,255,899 common shares with a maximum consideration of US$6,297,580 or CAD$8,373,263. Barakett will be eligible to receive Earn Out Shares for a period of 12 months on the following basis: 1. upon GLDH obtaining all of (i) the Long Beach Recreational License; (ii) the San Diego Medical License; (iii) the San Diego Recreational License; and (iv) the San Diego State License (“Milestone I”), the issuance of Earn Out Shares to Barakett totalling 5,627,950 shares (50% of the total Earn Out Shares); 2. upon GLDH achieving total attributable revenues of at least US$3,300,000 over a period of three consecutive months from each of the Long Beach dispensary, the San Diego dispensary and Las Vegas ShowGrow (“Milestone II”), the issuance of Earn Out Shares to Barakeet totalling 4,502,360 (40% of the total Earn Out Shares); and 3. prior to the completion of Milestone I and Milestone II, and upon completion of a certain audit of GLDH showing no taxes outstanding or any unknown material liabilities for GLDH, the issuance of Earn Out Shares to Barakett totalling 1,125,589 shares (10% of the total Earn Out Shares). Additionally, the Company made an investment into GLDH by way of a US$5,200,000 senior secured convertible note (the “Note”) bearing interest at a rate of 20% per annum to be repaid to the Company on 28 November 2020 unless converted by the Company in accordance with the agreement. The Note is secured by a general security agreement and a UCC-1 financing statement in all U.S. states where GLDH has assets. Barakett provided a personal guarantee to the Company for the Note. In order for the Company to fund the Note: 1. the Company entered into a loan agreement with Australis, whereby Australis provided the Company a two-year US$4,000,000 loan (Note 9); and 2. Australis exercised 3,206,160 warrants at a price of CAD$0.50 per common share for aggregate proceeds of approximately US$1,200,000 converted using an exchange rate of 0.7518 (Note 11). Definitive Agreement (Superseding Interim Agreement) On 3 July 2019, the Company entered into the following agreements with GLDH and other third parties: 1. a definitive asset purchase agreement (the “Purchase Agreement”) between the Company’s wholly owned subsidiary, NMG Long Beach, LLC (“NMG LB”), GLDH and Airport Collective, Inc. to acquire 100% ownership interest in GLDH’s Long Beach, California dispensary; 2. a settlement agreement (“NMG SD Settlement Agreement”) between the Company and its subsidiaries, and GLDH and its subsidiaries, to acquire a 60% ownership interest in GLDH’s San Diego, California dispensary; and 3. a lease assignment (the “Lease Assignment Agreement”) on the San Diego operation between the Company’s 60%-owned subsidiary, NMG San Diego, LLC (“NMG SD”), Green Road, LLC, Show Grow San Diego, LLC (“SGSD”), and SJJR LLC. The Purchase Agreement, NMG SD Settlement Agreement and Lease Assignment agreement supersede the Interim Agreement and are subject to certain closing conditions including receipt of applicable licences. 1. The Purchase Agreement was executed under the following terms: The purchase price is USD$6,700,000 (the “Purchase Price”). The consideration under the Purchase Agreement includes the following on closing: i The USD$5,200,000 Note is to be applied towards the Purchase Price; and ii. USD$1,500,000 to be paid in common shares of the Company at a price of CAD$0.7439 per common share to a maximum of 2,681,006 common shares (the “Share Payment”) (issued) (Note 11) upon NMG LB receiving the transfer of all licenses, permits and BCC authorizations for NMG LB to conduct medical and adult-use commercial cannabis retail operations. The Share Payment is subject to reduction in the event there are undisclosed liabilities by GLDH and Airport Collective. 2. The NMG SD Settlement Agreement’s consideration includes the following on closing: i. USD$500,000 to be paid in common shares (624,380 common shares issued ) (Note 11) to SGSD at a share price equal to the maximum allowable discount pursuant to Canadian Securities Exchange policies, upon execution of the settlement agreement; ii. USD$750,000 to be paid in common shares to Barakett at a price of CAD$0.7439 per common share to a maximum of 1,340,502 Common Shares (the “DB Share Payment”) upon NMG SD receiving all licenses, permits and authorizations for NMG SD to conduct medical commercial cannabis retail operations. The DB Share Payment is subject to reduction whereby the reduction is tied to Barakett agreeing to pay the Company 40% of the NMG SD start-up costs; and iii. USD$750,000 to be paid in common shares to Barakett at a price of CAD$0.7439 per common share to a maximum of 1,340,502 common shares (the “DB Additional Shares Payment”) upon NMG SD receiving all licenses, permits and authorizations for NMG SD to conduct adult-use commercial cannabis retail operations. The DB Additional Shares Payment is subject reduction whereby the reduction is tied to Barakett agreeing to pay the Company 40% of the NMG SD start-up costs. 3. The Lease Assignment Agreement was executed under the following terms: The Company is required to issue cash and share payments totaling USD$2,283,765 to the landlord as follows: i. USD$750,000, payable in common shares (1,031,725 common shares issued) (Note 11) at a share price equal to the maximum allowable discount pursuant to Canadian Securities Exchange policies, upon execution of the assignment agreement; ii. USD$783,765, payable in cash, within 5 business days following execution of the assignment agreement (paid); and iii. USD$750,000, payable in cash, including interest at 5% per annum, upon receipt of the San Diego Conditional Use Permit allowing adult-use commercial cannabis retail operations. Additionally: 1. The Company is to provide a loan to GLDH in the amount of USD$200,000 at an interest rate of 12% per annum, accrued and compounded quarterly and due within 3 years (provided); 2. The Company is to enter into a consulting agreement with Barakett through NMG LB to provide certain consulting and advisory services to NMG LB, agreeing to pay Barakett a total of USD$200,000 ($50,000 paid in fiscal 2019 and additional $90,000 paid during the period); 3. The Company will forgive approximately USD$800,000 for prior operating loans advanced by the Company to GLDH; and; 4. The Company licenses certain intellectual property from Green Light District Management, LLC and GLDH (collectively referred to as “Licensor”). The Licensor grants the Company a perpetual license to utilize its operational intellectual property consisting of customer data, sales data, customer outreach strategies standard operating procedures, and other proprietary operational intellectual property. Licensor grants the Company a license for 2 years to utilize intellectual property such as trademarks and branding (the “Branding IP”). As consideration for the licenses, the Company has agreed to utilize the Branding IP until 19 June 2021 at the Company’s premises and at the San Diego retail locations for a period of 2 years from operations commencing at that location. Additionally, the Company agreed to pay the Licensor 3% of gross receipts from sales at the Company’s premises. The total investment in GLDH at 31 January 2020 and 31 July 2019 is as follows 31 January 2020 31 July 2019 Opening balance $ 7,373,036 $ — Note receivable — 5,200,000 Share issuances 2,750,000 — Interest income accrued on the Note 520,000 693,333 Advances for working capital 1,285,960 666,876 Lease Assignment Agreement payment — 783,765 Foreign exchange (42,617 ) 29,062 Ending balance $ 11,886,379 $ 7,373,036

Other Agreements

Other Agreements	6 Months Ended
	Jan. 31, 2020
Other Agreement [Abstract]
Other Agreements	19. Other Agreements The Company and NMG Cathedral City (“NMG CC”) entered into a management and administrative services agreement (the “Management Agreement”) with Satellites Dip, LLC, (“SD”), a licensed cannabis business conducting commercial cannabis activity within the state of California. The one year Management Agreement commenced on 6 June 2019 and encompassed the following: a. Management Fee: NMG CC will be paid a management fee of 30% of Net Profits or $10,000 per month, whichever is greater; b. Brand Licensing: NMG CC shall work to broker commercial arrangements between SD and third-party cannabis brand owners whereby SD licenses commercial cannabis brands from third parties in connection with SD’s commercial cannabis activity in exchange for a license fee; c. Equipment and Capital: NMG CC shall furnish all equipment and machinery necessary for SD’s manufacturing of the Branded Products. Any equipment provided by NMG CC to SD shall be owned by NMG CC in its entirety and, subject to SD’s approval of the terms, leased to SD pursuant to an Equipment Lease Agreement entered into between NMG CC and SD, dated 6 June 2019; and d. Loan: The Parties have entered into a certain secured loan agreement dated 6 June 2019 whereby NMG CC has loaned SD $250,000 (the “Loan”) to be used solely in connection with SD’s commercial cannabis activity. The Loan shall be due and payable on 6 June 2020 (the “Maturity Date”) and shall bear interest at a rate of 12% per annum which shall be accrued, compounded quarterly and payable on the Maturity Date. The Loan is secured by a security interest in and to all of SD’s assets. On 30 November 2019, NMG CC entered into a settlement and release agreement (the “Settlement Agreement”) with SD whereby NMG CC and SD agreed to terminate the Management Agreement and to enter into a mutual release of any and all claims related to the Management Agreement, subject to the terms of the Settlement Agreement. As of 30 November 2019, SD owed NMG CC management fees (the “Monies Owed”) under the Management Agreement. In consideration of NMG CC’s discharge of the Monies Owed, SD has agreed to pay NMG CC one-hundred percent (100%) of all proceeds received from the sale of all or any part of its inventory (the “Inventory”) as of 1 November 2019. Pursuant to the Settlement Agreement, SD shall provide monthly updates of the remaining Inventory until the Inventory has been fully exhausted. NMG CC will determine the sale price for any item in Inventory subject to the Settlement Agreement. Brand Director Agreement On 30 November 2019, NMG CC entered into a brand director agreement (the “Brand Director Agreement”) with SD. Pursuant to the Brand Director Agreement, SD has engaged NMG CC to provide certain advisory and brand director services in connection with SD’s manufacture of Company-branded products, as well as certain other products (the “Managed Products”) as agreed to by NMGCC (the “Brand Director Services”). The initial term of the Brand Director Agreement is six months and the parties may renew the Brand Director Agreement for successive three-month renewal periods. The Brand Director Services include: (a) managing SD’s production of the Managed Products; (b) payment of a reimbursement fee to SD equal to the amount of direct costs and direct taxes applicable to the Managed Products; (c) managing inventory of the Managed Products; and (d) directing SD to enter into distribution agreements and sale agreements with third-party commercial cannabis licensees for the distribution and sale of the Managed Products in accordance with applicable law. Pursuant to the Brand Director Agreement, NMG CC will pay a monthly fee (the “Contribution Fee”) of $5,000 to SD. In connection with the Brand Director Agreement, as partial repayment for the principal and interest accrued under a certain loan agreement (the “Loan Agreement”) between NMG CC and SD dated 6 June 2019, SD waives payment of the Contribution Fee for the first five (5) months of the Brand Direction Agreement. In consideration for the Brand Director Services, SD (as the “Licensee”) has agreed to pay NMG CC (in its capacity as the “Brand Director”) a brand director fee for each calendar month during the term of the Brand Director Agreement, whereby Licensee shall pay to Brand Director a fee to be calculated as follows: (x) net revenue for a single calendar month, multiplied by, (y) seventy-five percent (75%); (z) plus any fees to be paid to NMG CC in connection with the equipment lease agreement (the “Equipment Lease Agreement”) dated 6 June 2019 (the “Equipment Lease Fee”) added to the product of (x) and (y), the (q) total amount shall be the fee paid to NMG CC. If the net revenue, minus the product of (x) and (y) is less than the Equipment Lease Fee in any given month, the difference shall carry over to the subsequent month, to be added to that month’s Equipment Lease Fee, or the difference may be paid by Licensee at its sole option. Brand License Agreement On 30 November 2019, DEP entered into a brand license agreement (the “License Agreement”) with SD. Pursuant to the License Agreement, DEP granted SD a non-exclusive, non-transferable, and non-sub-licensable right (the “License”) to use certain licensed marks in connection with or on licensed products, solely in connection with SD’s commercial cannabis activity in California. In consideration for the License, SD will pay DEP a monthly fee equal to $100, payable on a quarterly basis. During the term of the License Agreement, SD must remain in compliance with all state and local cannabis rules and regulations in California, and maintain valid commercial cannabis licenses. SD will follow the guidance of DEP and only utilize packaging and labelling materials purchased from (or at the direction of) DEP. The License Agreement will be in full force and effect for the duration of the Brand Director Agreement. Equipment Purchase Agreement On 30 November 2019, NMG CC and SD entered into an equipment purchase agreement (the “Equipment Purchase Agreement”) pursuant to which NMG CC agreed to purchase certain equipment (the “Equipment”) from SD. The aggregate purchase price for the Equipment is $235,685 and will be applied to the outstanding balance under the Loan Agreement. First Amendment to the Equipment Lease Agreement On 30 November 2019, NMG CC and SD entered into an amendment (the “First Amendment”) to the Equipment Lease Agreement. Pursuant to the First Amendment, NMG CC and SD amended (i) the term of the Equipment Lease Agreement to be coterminous with the Brand Director Agreement; and (ii) to update the equipment being leased pursuant to the Equipment Lease Agreement and to update the monthly rental rate for the equipment being leased. Release & Satisfaction of Loan Agreement On 30 November 2019, NMG CC and SD entered into a release and satisfaction of loan agreement (the “Release Agreement”). Pursuant to the Release Agreement, NMG CC agreed that all indebtedness of SD to NMG CC arising from the Loan Agreement (and promissory note issued in connection with the Loan Agreement) is hereby satisfied and discharged in full. The release is granted based on SD’s obligations and duties pursuant to the Equipment Purchase Agreement and its five (5) month waiver of the Contribution Fee under the Brand Director Agreement. The Company recorded a loss of $239,328 related to the Settlement Agreement with SD.

Lease Liabilities

Lease Liabilities	6 Months Ended
	Jan. 31, 2020
Leases [Abstract]
Lease Liabilities	20. Lease Liabilities a) On 10 November 2017, NMG entered into a revised five-year lease agreement for the property located at 3375 Pepper Lane, Las Vegas, NV, containing approximately 18,000 square feet. The Company has four options to extend the lease and each option is for five years. The monthly rent was $12,500 plus common area expenses, which increased to $12,875 plus common area expenses on 1 January 2019. The guaranteed minimum monthly rent is subject to a 2% increase on each anniversary date of the lease. b) On 9 April 2019, NMG entered into a three-year lease agreement for the property located at 6420 Sunset Corporate Drive, Las Vegas, NV, containing approximately 7,700 square feet. The Company has one option to extend the lease for an additional three-year term and an option to purchase the property at any point during the initial term. The monthly rent is $6,026 plus $1,129 in common area expenses, totaling $7,156 every month. On adoption of ASC 842, Lease Accounting, the Company recognized right-of-use assets (Notes 7 and 13), and a corresponding increase in lease liabilities, in the amount of $1,187,116 which represented the present value of future lease payments using a discount rate of 12% per annum. The Company adopted the modified retrospective approach on adopting ASC 842 and accordingly the adoption was made effective 1 August 2019, with no restatement of the prior year comparatives. During the six months ended 31 January 2020, the Company recorded a lease expense of $100,871 related to the accretion of lease liabilities and the depreciation of right-of-use assets. Supplemental cash flow information related to leases was as follows: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 100,871 Right-of-use assets obtaining in exchange for lease obligations: Operating leases $ 1,187,116 Weighted-average remaining lease term – operating leases 7.19 years Weighted-average discount rate – operating leases 12 % Maturities of lease liabilities were as follows: Year Ending 31 July Operating Leases 2020 $ 109,631 2021 223,398 2022 240,530 2023 248,403 2024 254,438 2025 257,827 2026 176,312 2027 179,838 2028 60,340 Total lease payments $ 1,750,717 Less imputed interest (649,019 ) Total $ 1,101,698 Less current portion (195,983 ) Long term portion 905,715

Subsequent Events

Subsequent Events	6 Months Ended
	Jan. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	21. Subsequent Events

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jan. 31, 2020
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation These condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July.
Cash and cash equivalents	Cash and cash equivalents Cash and cash equivalents include highly liquid investments with original maturities of three months or less.
Amounts receivable	Amounts receivable Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As at 31 January 2020 and 31 July 2019, the Company has no allowance for doubtful accounts.
Revenue recognition	Revenue recognition During the year ended 31 July 2018, the Company recognized revenue in accordance with ASC 605, “Revenue Recognition”. Revenue was considered realized or realizable and earned when all of the following criteria were met: (1) persuasive evidence of an arrangement exists, (2) the sales price is fixed or determinable, (3) collectability is reasonably assured, and (4) products have been shipped and the customer has taken ownership and assumed risk of loss. On 1 August 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers” and all of the related amendments, which are also codified into ASC 606. The Company elected to adopt this guidance using the modified retrospective method. The adoption of this guidance did not have a material effect on the Company’s financial position, results of operations or cash flows. Under the new standard, the Company recognizes a sale as follows: The Company recognizes revenue product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement. Upon transfer of control, the Company has no further performance obligations. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.
Inventory	Inventory Inventory consists of raw material, work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its raw material, finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost. The Company periodically reviews its inventory for obsolete and potentially impaired items. As at 31 January 2020 and 31 July 2019, the Company has no reserve for inventory.
Property and equipment	Property and equipment Property and equipment are stated at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of 15 years or the term of the lease
Brands and licenses	Brands and licenses Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses have indefinite lives; therefore no amortization is recognized.
Income taxes	Income taxes Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not.
Basic and diluted net loss per share	Basic and diluted net loss per share The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.
Comprehensive loss	Comprehensive loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the condensed consolidated interim financial statements. As at 31 January 2020 and 31 July 2019, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements.
Foreign currency translation	Foreign currency translation The Company’s functional currency is the Canadian dollar and its reporting currency is the U.S. dollars. The Company’s subsidiaries have a functional currency of U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of income.
Stock-based compensation	Stock-based compensation The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur.
Fair value measurements	Fair value measurements The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. Other current financial assets and current financial liabilities have fair values that approximate their carrying values.
Use of estimates and assumptions	Use of estimates and assumptions The preparation of condensed consolidated interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates.
Lease accounting	Lease accounting Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that do not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment.
Comparative figures	Comparative figures Certain comparative figures have been adjusted to conform to the current year’s presentation.

Nature and Continuance of Ope_2

Nature and Continuance of Operations (Tables)	6 Months Ended
	Jan. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of consolidation of entities and its ownership interest	Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100% 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100% 14 November 2017 NMG Retail LLC Nevada, USA 75% 14 September 2018 NMG Long Beach LLC California, USA 100% 18 December 2018 NMG Cathedral City LLC California, USA 100% 4 January 2019 NMG Chula Vista LLC California, USA 51% 10 January 2019 NMG San Diego LLC California, USA 60% 30 January 2019
Schedule of ownership interest by equity method investment in consolidation	Name Jurisdiction Ownership Date of acquisition or formation NMG Ohio LLC Ohio, USA 30% 27 April 2017

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	6 Months Ended
	Jan. 31, 2020
Accounting Policies [Abstract]
Schedule of property and equipment estimated useful lives	Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of 15 years or the term of the lease

Financial Instruments (Tables)

Financial Instruments (Tables)	6 Months Ended
	Jan. 31, 2020
Investments, All Other Investments [Abstract]
Schedule of financial assets at fair value	As at 31 January 2020 As at 31 July 2019 Financial assets at fair value Cash $ 3,374,079 $ 9,004,716 Convertible loan receivable 948,310 52,225 Total financial assets at fair value $ 4,322,389 $ 9,056,941

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jan. 31, 2020
Inventory Disclosure [Abstract]
Schedule of inventory	31 January 2020 31 July 2019 Work in progress $ 233,818 $ 208,417 Finished goods 652,121 615,108 Consumables 636,321 566,894 Total $ 1,522,260 $ 1,390,419

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jan. 31, 2020
Property And Equipment
Schedule of property and equipment	Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Right-of-use Assets Total Cost: Balance, 31 July 2018 $ 24,586 $ 435,109 $ 261,957 $ 27,694 $ 38,717 $ 1,644 $ 1,993,928 $ — $ 2,783,635 Additions 7,491 28,647 36,004 23,414 — 528 272,078 — 368,162 Balance, 31 July 2019 32,077 463,756 297,961 51,108 38,717 2,172 2,266,006 — 3,151,797 Additions 40,869 — 247,762 9,022 — — 740,503 — 1,038,156 ASC 842 adoption (Notes 13 and 20) — — — — — — — 1,187,116 1,187,116 Balance, 31 January 2020 72,946 463,756 545,723 60,130 38,717 2,172 3,006,509 1,187,116 5,377,069 Accumulated Depreciation: Balance, 31 July 2018 3,177 41,169 25,446 2,554 5,500 228 89,663 — 167,737 Depreciation 5,119 73,597 44,547 4,546 7,751 358 153,642 — 289,560 Balance, 31 July 2019 8,296 114,766 69,993 7,100 13,251 586 243,305 — 457,297 Depreciation 4,276 38,132 24,188 4,253 3,907 200 82,899 — 157,855 Asset lease expense (Note 20) — — — — — — — 85,418 85,418 Balance, 31 January 2020 12,572 152,898 94,181 11,353 17,158 786 326,204 85,418 700,570 Net Book Value: As at 31 July 2018 21,409 393,940 236,511 25,140 33,217 1,416 1,904,265 — 2,615,898 As at 31 July 2019 23,781 348,990 227,968 44,008 25,466 1,586 2,022,701 — 2,694,500 As at 31 January 2020 $ 60,374 $ 310,858 $ 451,542 $ 48,777 $ 21,559 $ 1,386 $ 2,680,305 $ 1,101,698 $ 4,676,499

Related Party Balances and Tr_2

Related Party Balances and Transactions (Tables)	6 Months Ended
	Jan. 31, 2020
Related Party Transactions [Abstract]
Schedule of related party transactions	For the three months ended 31 January 2020 For the three months ended 31 January 2019 For the six months ended 31 January 2020 For the six months ended 31 January 2019 A company controlled by the President and Interim Chief Executive Officer Management fees $ 37,511 $ — $ 79,378 $ — A company controlled by the Chief Financial Officer and a director Management fees Accounting fees 25,232 — — 11,611 47,900 — — 18,519 A company controlled by a former director and former President of NMG Management fees 8,333 66,992 16,666 100,646 A company controlled by the Corporate Secretary Management fees Consulting fees 25,322 1,552 7,476 — 30,989 3,103 18,990 — A company controlled by the former Chief Executive Officer and a former director Management fees — — 9,401 — $ 97,950 $ 86,079 $ 187,437 $ 138,155

Capital Stock (Tables)

Capital Stock (Tables)	6 Months Ended
	Jan. 31, 2020
Stockholders' Equity Note [Abstract]
Schedule of fair value assumptions for stock options granted	Expected life of the options 5 years Expected volatility 265 % Expected dividend yield 0 % Risk-free interest rate 2.03 % Expected life of the options 5 years Expected volatility 140 % Expected dividend yield 0 % Risk-free interest rate 1.28 % Expected life of the options 5 years Expected volatility 140 % Expected dividend yield 0 % Risk-free interest rate 1.37 % Expected life of the options 5 years Expected volatility 140 % Expected dividend yield 0 % Risk-free interest rate 1.43 %
Schedule of stock option activity	Number of options Weighted average exercise price Weighted average contractual term remaining (in years) Aggregate intrinsic value Outstanding at 31 July 2018 4,025,000 CAD$0.65 4.34 CAD$ - Granted 2,050,000 CAD$0.57 Outstanding at 31 July 2019 6,075,000 CAD$0.62 3.69 CAD$1,675,750 Granted 3,300,000 CAD$0.88 Cancelled (400,000) CAD$0.88 Outstanding at 31 January 2020 8,975,000 CAD$0.71 3.64 CAD$ 1,750 Vested and fully exercisable at 31 January 2020 6,075,000 CAD$0.62 3.18 CAD$ 1,750
Schedule of warrants activity	Number of warrants Weighted average exercise price Outstanding at 31 July 2018 10,106,820 CAD$0.89 Issued 28,415,284 CAD$0.93 Exercised (16,007,333) CAD$0.50 Outstanding at 31 July 2019 22,514,771 CAD$1.22 Exercised (165,715) CAD$0.73 Expired (9,933,772) CAD$0.89 Outstanding at 31 January 2020 12,415,284 CAD$1.49
Schedule of number of warrants outstanding and exercisable	Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$1.50 17 May 2023 635,150 CAD$1.25 16 May 2023 12,415,284

Supplemental Disclosures with_2

Supplemental Disclosures with Respect to Cash Flows (Tables)	6 Months Ended
	Jan. 31, 2020
Supplemental Disclosures With Respect To Cash Flows
Supplemental disclosures with respect to cash flows	Three Month Period Ended 31 January Six Month Period Ended 31 January 2020 2019 2020 2019 Cash paid during the period for interest $ — $ — $ — $ — Cash paid during the period for income taxes $ — $ — $ — $ —

Investment in NMG Ohio LLC (Tab

Investment in NMG Ohio LLC (Tables)	6 Months Ended
	Jan. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
Schedule of reconciliation and summarized financial information of Investment in NMG Ohio LLC	31 October 2019 31 July 2019 Opening balance $ 3,465,902 $ 77,600 Acquisition costs: Common shares issued to vendors at fair value — 1,448,805 Acquisition costs: Cash payments to vendors — 1,181,250 Dispensary build-out related costs 16,469 573,633 License fees — 100,000 Equity pickup 87,651 56,466 Foreign exchange (1,377 ) 28,148 Total $ 3,568,645 $ 3,465,902 31 October 2019 Current assets $ 768,603 Non-current assets 853,383 Total assets 1,621,986 Current liabilities 465,933 Non-current liabilities — Total liabilities 465,933 Revenues 961,444 Gross profit 420,904 Net income 292,171 Net income attributable to the Company $ 87,651

Investment in and advances to_2

Investment in and advances to GLDH (Tables)	6 Months Ended
	Jan. 31, 2020
Long-term Investments [Abstract]
Schedule of total investment in GLDH	31 January 2020 31 July 2019 Opening balance $ 7,373,036 $ — Note receivable — 5,200,000 Share issuances 2,750,000 — Interest income accrued on the Note 520,000 693,333 Advances for working capital 1,285,960 666,876 Lease Assignment Agreement payment — 783,765 Foreign exchange (42,617 ) 29,062 Ending balance $ 11,886,379 $ 7,373,036

Lease Liabilities (Tables)

Lease Liabilities (Tables)	6 Months Ended
	Jan. 31, 2020
Leases [Abstract]
Schedule of supplemental cash flow information related to leases	Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 100,871 Right-of-use assets obtaining in exchange for lease obligations: Operating leases $ 1,187,116 Weighted-average remaining lease term – operating leases 7.19 years Weighted-average discount rate – operating leases 12 %
Schedule of Maturities of lease liabilities	Year Ending 31 July Operating Leases 2020 $ 109,631 2021 223,398 2022 240,530 2023 248,403 2024 254,438 2025 257,827 2026 176,312 2027 179,838 2028 60,340 Total lease payments $ 1,750,717 Less imputed interest (649,019 ) Total $ 1,101,698 Less current portion (195,983 ) Long term portion 905,715

Nature and Continuance of Ope_3

Nature and Continuance of Operations (Details)	Jan. 31, 2020
DEP Nevada Inc. ("DEP Nevada")
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership	100.00%
Nevada Medical Group LLC (NMG)
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership	100.00%
NMG Retail LLC
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership	75.00%
NMG Long Beach LLC
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership	100.00%
NMG Cathedral City LLC
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership	100.00%
NMG Chula Vista LLC
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership	51.00%
NMG San Diego LLC
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership	60.00%

Nature and Continuance of Ope_4

Nature and Continuance of Operations (Details 1)	Jan. 31, 2020
NMG Ohio LLC
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	30.00%

Nature and Continuance of Ope_5

Nature and Continuance of Operations (Details Narrative)	6 Months Ended
	Jan. 31, 2020	May 31, 2004
State of incorporation	Delaware
Date of incorporation	Nov. 5, 1998
Kaleidoscope Venture Capital, Inc
Ownership percentage		100.00%

Significant Accounting Polici_4

Significant Accounting Policies (Details)	6 Months Ended
	Jan. 31, 2020
Office Equipment
Estimated useful lives	7 years
Cultivation Equipment
Estimated useful lives	7 years
Production Equipment
Estimated useful lives	7 years
Kitchen Equipment
Estimated useful lives	7 years
Vehicles
Estimated useful lives	7 years
Vault Equipment
Estimated useful lives	7 years
Leasehold Improvements
Estimated useful lives	shorter of 15 years or the term of the lease

Financial Instruments (Details)

Financial Instruments (Details) - USD ($)	Jan. 31, 2020	Jul. 31, 2019
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash	$ 3,374,079	$ 9,004,716
Convertible loan receivable	948,310	52,225
Total financial assets at fair value	$ 4,322,389	$ 9,056,941

Financial Instruments (Details

Financial Instruments (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended
	Jan. 31, 2020	Oct. 31, 2019	Jan. 31, 2019	Oct. 31, 2018	Jan. 31, 2020	Jan. 31, 2019	Jul. 31, 2019
Investments, All Other Investments [Abstract]
Retained Earnings (Accumulated Deficit)	$ (12,657,211)				$ (12,657,211)		$ (10,525,062)
Net Income (Loss) Attributable to Parent	(1,235,352)	$ (896,797)	$ (1,763,679)	$ (211,795)	(2,132,149)	$ (1,975,474)
Negative cash flows from operations					(2,565,786)	$ (915,104)
Working capital deficit	$ 5,443,575				$ 5,443,575

Inventory (Details)

Inventory (Details) - USD ($)	Jan. 31, 2020	Jul. 31, 2019
Inventory Disclosure [Abstract]
Work in progress	$ 233,818	$ 208,417
Finished goods	652,121	615,108
Consumables	636,321	566,894
Total	$ 1,522,260	$ 1,390,419

Convertible loan receivable (De

Convertible loan receivable (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019	Jul. 31, 2019
Convertible loan receivable [Line Items]
Convertible loan receivable	$ 948,310		$ 948,310		$ 52,225
Accrued interest income	18,000		36,000
Interests receivable	63,000	$ 27,000	63,000	$ 27,000	$ 27,000
NMG
Convertible loan receivable [Line Items]
Loan bears interest per month	6,000		$ 6,000
Percentage of monthly management fee			66.67%
CCG | Convertible loan agreement
Convertible loan receivable [Line Items]
Proceeds from fund construction	1,250,000		$ 1,250,000
Loan bears interest per month	$ 6,000		$ 6,000
Outstanding units percentage	40.00%		40.00%

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jul. 31, 2019	Jul. 31, 2018
Cost:
Balance	$ 3,151,797	$ 2,783,635	$ 2,783,635
Additions	1,038,156		368,162
ASC 842 adoption (Note 20)	1,187,116
Balance	5,377,069		3,151,797
Accumulated Depreciation:
Balance	457,297	167,737	167,737
Depreciation	157,855	141,901	289,560
Asset lease expense (Note 20)	85,418
Balance	700,570		457,297
Net Book Value
Net Book Value:	4,676,499		2,694,500	$ 2,615,898
Office Equipment
Cost:
Balance	32,077	24,586	24,586
Additions	40,869		7,491
ASC 842 adoption (Note 20)	0
Balance	72,946		32,077
Accumulated Depreciation:
Balance	8,296	3,177	3,177
Depreciation	4,276		5,119
Asset lease expense (Note 20)	0
Balance	12,572		8,296
Net Book Value
Net Book Value:	60,374		23,781	21,409
Cultivation Equipment
Cost:
Balance	463,756	435,109	435,109
Additions	0		28,647
ASC 842 adoption (Note 20)	0
Balance	463,756		463,756
Accumulated Depreciation:
Balance	114,766	41,169	41,169
Depreciation	38,132		73,597
Asset lease expense (Note 20)	0
Balance	152,898		114,766
Net Book Value
Net Book Value:	310,858		348,990	393,940
Production Equipment
Cost:
Balance	297,961	261,957	261,957
Additions	247,762		36,004
ASC 842 adoption (Note 20)	0
Balance	545,723		297,961
Accumulated Depreciation:
Balance	69,993	25,446	25,446
Depreciation	24,188		44,547
Asset lease expense (Note 20)	0
Balance	94,181		69,993
Net Book Value
Net Book Value:	451,542		227,968	236,511
Kitchen Equipment
Cost:
Balance	51,108	27,694	27,694
Additions	9,022		23,414
ASC 842 adoption (Note 20)	0
Balance	60,130		51,108
Accumulated Depreciation:
Balance	7,100	2,554	2,554
Depreciation	4,253		4,546
Asset lease expense (Note 20)	0
Balance	11,353		7,100
Net Book Value
Net Book Value:	48,777		44,008	25,140
Vehicles
Cost:
Balance	38,717	38,717	38,717
Additions	0		0
ASC 842 adoption (Note 20)	0
Balance	38,717		38,717
Accumulated Depreciation:
Balance	13,251	5,500	5,500
Depreciation	3,907		7,751
Asset lease expense (Note 20)	0
Balance	17,158		13,251
Net Book Value
Net Book Value:	21,559		25,466	33,217
Vault Equipment
Cost:
Balance	2,172	1,644	1,644
Additions	0		528
ASC 842 adoption (Note 20)	0
Balance	2,172		2,172
Accumulated Depreciation:
Balance	586	228	228
Depreciation	200		358
Asset lease expense (Note 20)	0
Balance	786		586
Net Book Value
Net Book Value:	1,386		1,586	1,416
Leasehold Improvements
Cost:
Balance	2,266,006	1,993,928	1,993,928
Additions	740,503		272,078
ASC 842 adoption (Note 20)	0
Balance	3,006,509		2,266,006
Accumulated Depreciation:
Balance	243,305	89,663	89,663
Depreciation	82,899		153,642
Asset lease expense (Note 20)	0
Balance	326,204		243,305
Net Book Value
Net Book Value:	2,680,305		2,022,701	1,904,265
Right of use Assets
Cost:
Balance	0	0	0
Additions	0		0
ASC 842 adoption (Note 20)	1,187,116
Balance	1,187,116		0
Accumulated Depreciation:
Balance	0	$ 0	0
Depreciation	0		0
Asset lease expense (Note 20)	85,418
Balance	85,418		0
Net Book Value
Net Book Value:	$ 1,101,698		$ 0	$ 0

Related Party Balances and Tr_3

Related Party Balances and Transactions (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Related Party Transaction [Line Items]
Management fees	$ 97,950	$ 86,079	$ 187,437	$ 138,155
Consulting fees	135,953	107,687	356,180	110,287
President and Interim Chief Executive Officer
Related Party Transaction [Line Items]
Management fees	37,511	0	79,378	0
Chief Financial Officer and a director
Related Party Transaction [Line Items]
Management fees	25,232	0	47,900	0
Accounting fees	0	11,611	0	18,519
Former director and former President
Related Party Transaction [Line Items]
Management fees	8,333	66,992	16,666	100,646
Corporate Secretary
Related Party Transaction [Line Items]
Management fees	25,322	7,476	30,989	18,990
Consulting fees	1,552	0	3,103	0
Former Chief Executive Officer and former director
Related Party Transaction [Line Items]
Management fees	$ 0	$ 0	$ 9,401	$ 0

Related Party Balances and Tr_4

Related Party Balances and Transactions (Details Narrative) - USD ($)	Jan. 31, 2020	Jul. 31, 2019
Related Party Transaction [Line Items]
Due to related party	$ 7,680	$ 12,952
Interim chief executive officer
Related Party Transaction [Line Items]
Due to related party	7,680	7,825
Chief financial officer
Related Party Transaction [Line Items]
Due to related party		$ 5,127

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 29, 2018	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019	Jul. 31, 2019
Accrued interest expense		$ 131,850	$ 32,362	$ 131,850	$ 32,362
Common stock share issued		101,853,217		101,853,217		97,279,891
Deferred finance costs				$ (822,494)
Accrued interest					176,090
Accretion expense					$ 176,090
Australis
Promissory note	$ 4,000,000
Interest rate	15.00%
Maturity terms	2 years
Common stock share issued	1,105,083
Early Repayment penalty				$ 200,000

Convertible debenture (Details

Convertible debenture (Details Narrative)	3 Months Ended		6 Months Ended			12 Months Ended
	Jan. 31, 2020USD ($)	Jan. 31, 2019USD ($)	Jan. 31, 2020CAD ($)shares	Jan. 31, 2020USD ($)shares	Jan. 31, 2019USD ($)	Jul. 31, 2019USD ($)	Jan. 31, 2020USD ($)	Oct. 30, 2018CAD ($)$ / shares	Oct. 30, 2018USD ($)
Short-term Debt [Line Items]
Beneficial conversion feature			$ 116,714	$ 88,797
Accrued interest expense						$ 98,392
Convertible debentures			$ 1,483,636				$ 1,128,750
Interest rate			11.30%				11.30%
Interest paid						72,623
Interest paid advanced						$ 88,821
Conversion shares issued | shares			2,909,091	2,909,091
Accrued interest and accretion	$ 131,850	$ 32,362		$ 131,850	$ 32,362
Australis | Investment Agreement
Short-term Debt [Line Items]
Unsecured convertible debenture								$ 1,600,000	$ 1,217,547
Acquired warrant unit price | $ / shares								$ 0.55
Interest rate								8.00%	8.00%

Capital Stock (Details)

Capital Stock (Details)	Oct. 01, 2019	Dec. 11, 2018	Jan. 23, 2020	Aug. 21, 2019
Stockholders' Equity Note [Abstract]
Expected life of the options	5 years	5 years	5 years	5 years

Capital Stock (Details 1)

Capital Stock (Details 1) - Stock options	Oct. 01, 2019$ / sharesshares	Dec. 11, 2018$ / sharesshares	Jan. 31, 2020CAD ($)$ / sharesshares	Jul. 31, 2019CAD ($)$ / sharesshares	Jul. 31, 2018USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Opening balance | shares			6,075,000	4,025,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares	250,000	2,050,000	3,300,000	2,050,000
Option cancelled | shares			(600,000)
Closing balance | shares			8,775,000	6,075,000	4,025,000
Number of options, Vested and fully exercisable | shares			6,075,000
Weighted average exercise price, opening balance | $ / shares			$ 0.62	$ 0.65
Weighted average exercise price, options granted | $ / shares	$ 0.93	$ 0.57	0.88	0.57
Weighted average exercise price, options Cancelled | $ / shares			0.88
Weighted average exercise price, closing balance | $ / shares			0.70	$ 0.62	$ 0.65
Weighted average exercise price, Vested and fully exercisable | $ / shares			$ 0.62
Weighted average contractual term remaining (in years)			3 years 7 months 14 days	3 years 8 months 8 days	4 years 4 months 2 days
Weighted average contractual term remaining (in years), Vested and fully exercisable			3 years 2 months 4 days
Aggregate intrinsic value			$ 1,750	$ 1,675,750	$ 0
Aggregate intrinsic value, Vested and fully exercisable | $			$ 1,750

Capital Stock (Details 2)

Capital Stock (Details 2) - $ / shares	1 Months Ended		6 Months Ended	12 Months Ended
	Jul. 16, 2019	Nov. 30, 2018	Jan. 31, 2020	Jul. 31, 2019	Nov. 14, 2019	Nov. 04, 2019	Sep. 12, 2019	Aug. 12, 2019
Closing balance			12,415,284
Weighted average exercise price, Issued	$ 0.90	$ 0.50
Weighted average exercise price, Exercised					$ 0.90	$ 0.90	$ 0.66	$ 0.66
Share purchase warrants and brokers' warrants
Opening balance			22,514,771	10,106,820
Issued				28,415,284
Closing balance			12,415,284	22,514,771
Weighted average exercise price, opening balance			$ 1.22	$ 0.89
Weighted average exercise price, Issued				0.93
Weighted average exercise price, Exercised			0.73	0.50
Weighted average exercise price, Expired			0.89
Weighted average exercise price, closing balance			$ 1.49	$ 1.22

Capital Stock (Details 3)

Capital Stock (Details 3) - $ / shares	6 Months Ended
	Jan. 31, 2020	Nov. 14, 2019	Nov. 04, 2019	Sep. 12, 2019	Aug. 12, 2019
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of warrants outstanding and exercisable	12,415,284
Warrants price per share		$ 0.90	$ 0.90	$ 0.66	$ 0.66
Exercise price CAD$1.50
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of warrants outstanding and exercisable	11,780,134
Exercise price	$ 1.50
Expiry dates	17 May 2023
Exercise price CAD$1.25
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of warrants outstanding and exercisable	635,150
Exercise price	$ 1.25
Expiry dates	16 May 2023

Capital Stock (Details Narrativ

Capital Stock (Details Narrative)	Nov. 14, 2019CAD ($)$ / sharesshares	Nov. 14, 2019USD ($)shares	Oct. 04, 2019CAD ($)shares	Oct. 04, 2019USD ($)shares	Oct. 01, 2019CAD ($)$ / sharesshares	Oct. 01, 2019USD ($)shares	Sep. 12, 2019CAD ($)$ / sharesshares	Sep. 12, 2019USD ($)shares	Aug. 12, 2019CAD ($)$ / sharesshares	Aug. 12, 2019USD ($)shares	Dec. 11, 2018CAD ($)$ / sharesshares	Dec. 11, 2018USD ($)shares	Nov. 02, 2018CAD ($)$ / sharesshares	Nov. 02, 2018USD ($)$ / sharesshares	Jan. 23, 2020CAD ($)$ / sharesshares	Jan. 23, 2020USD ($)shares	Aug. 21, 2019CAD ($)$ / sharesshares	Aug. 21, 2019USD ($)shares	Jul. 16, 2019CAD ($)$ / sharesshares	Jul. 16, 2019USD ($)shares	May 28, 2019CAD ($)$ / sharesshares	May 28, 2019USD ($)shares	May 17, 2019CAD ($)$ / sharesshares	May 17, 2019USD ($)$ / sharesshares	Jan. 31, 2019USD ($)shares	Nov. 30, 2018CAD ($)$ / sharesshares	Nov. 30, 2018USD ($)shares	Nov. 29, 2018USD ($)shares	Jan. 31, 2020CAD ($)$ / sharesshares	Jan. 31, 2020USD ($)	Jan. 31, 2020CAD ($)$ / sharesshares	Jan. 31, 2020USD ($)shares	Jan. 31, 2019USD ($)	Jul. 31, 2019$ / sharesshares	Jan. 31, 2020$ / sharesshares	Nov. 04, 2019$ / shares	Jul. 31, 2019$ / sharesshares	May 14, 2019USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Capital stock, par value | $ / shares																																			$ 0.0001		$ 0.0001
Capital stock, shares authorized																													900,000,000		900,000,000			900,000,000	900,000,000		900,000,000
Preferred stock converted into common shares																															2,909,091	2,909,091
Common stock shares issued																			7,333	7,333						3,206,160	3,206,160
Warrants shares issued																			7,333	7,333						3,206,160	3,206,160
Warrant exercisable price per share | $ / shares																			$ 0.90							$ 0.50
Number of warrants exercised			22,727	22,727			38,912	38,912	81,591	81,591
Proceeds from issuance of common stock							$ 25,682	$ 19,450											$ 6,600	$ 5,057						$ 1,603,080	$ 1,205,196					$ 90,840	$ 5,818,300
Exercised	$ 20,236	$ 15,291	$ 20,454	$ 15,360					$ 53,850	$ 40,765
Common stock shares issued upon exercise of warrants	22,485	22,485	22,727	22,727			38,912	38,912	81,591	81,591
Warrants price per share | $ / shares	$ 0.90						$ 0.66		$ 0.66																											$ 0.90
Share purchase warrants and brokers' warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrant exercisable price per share | $ / shares																																		$ 0.93
Warrants price per share | $ / shares																													$ 0.73		$ 0.73			$ 0.50
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted					250,000	250,000					2,050,000	2,050,000																			3,300,000	3,300,000		2,050,000
Exercise price | $ / shares					$ 0.93						$ 0.57																				$ 0.88			$ 0.57
Fair value of stock options					$ 191,960	$ 145,045											$ 1,818,232	$ 1,373,856
Stock-based compensation																													$ 52,316	$ 39,668	$ 68,979	$ 52,259
Percentage of issued and outstanding common shares																													10.00%		10.00%				10.00%
Purchase agreement NMG SD settlement agreement and lease assignment agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock shares issued									4,337,111	4,337,111
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted															200,000	200,000
Exercise price | $ / shares															$ 0.88
Fair value of stock options															$ 90,608	$ 68,645
Stock-based compensation																													$ 2,495	1,890	$ 2,495	1,890
Australis
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock shares issued																												1,105,083
Number of warrants exercised																					12,793,840	12,793,840
Finance fee fair valued | $																												$ 822,494
Exercised																					$ 6,396,920	$ 4,746,515
Common stock shares issued upon exercise of warrants																					12,793,840	12,793,840
Warrants price per share | $ / shares																					$ 0.50
Australis | Senior secured note
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Repayment of senior debt | $																						$ 4,495,890
Australis | Investment Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock shares issued																									1,768,545
Common stock share subscriptions receivable | $																									$ 787,123								$ 787,123
Consultant | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of stock options											$ 1,165,117	$ 881,644
Toro Pacific Management Inc. (the "Transferor")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Escrowed shares issued																																						70,500
Escrowed shares fair value | $																																						$ 22,689
NMG Ohio LLC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock shares issued																									2,380,398
Common stock value | $																									$ 1,448,805
Acquiring revenue remaining performance obligation																									70.00%								70.00%
Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted																	2,850,000	2,850,000
Exercise price | $ / shares																	$ 0.88
Expired															200,000	200,000	400,000	400,000
Stock-based compensation																													$ 431,619	$ 327,879	$ 798,398	$ 604,866
Options vest six months from the date of grant | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage					25.00%	25.00%
Options vest six months from the date of grant | Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage															25.00%	25.00%
Options vest six months from the date of grant | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage																	25.00%	25.00%
Options vest twelve months from the date of grant | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage					25.00%	25.00%
Options vest twelve months from the date of grant | Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage															25.00%	25.00%
Options vest twelve months from the date of grant | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage																	25.00%	25.00%
Options vest eighteen months from the date of grant | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage					25.00%	25.00%
Options vest eighteen months from the date of grant | Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage															25.00%	25.00%
Options vest eighteen months from the date of grant | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage																	25.00%	25.00%
Options vest twenty-four months from the date of grant | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage					25.00%	25.00%
Options vest twenty-four months from the date of grant | Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage															25.00%	25.00%
Options vest twenty-four months from the date of grant | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option vesting period percentage																	25.00%	25.00%
Private placement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maturity Period																							48 months	48 months
Private placements shares issued													16,000,000	16,000,000
Subscription receipts per price | (per share)													$ 0.40	$ 0.30									$ 1.25	$ 0.93
Proceeds from issuance of private placement													$ 6,400,000	$ 4,883,840									$ 14,726,130	$ 10,956,241
Cash paid for finder fees | $														$ 152,720
Common stock shares issued													322,581	322,581
Common stock value | $														$ 221,691
Warrant exercisable price per share | $ / shares													$ 0.50										$ 1.50
Number of units issued under private placement																							11,780,904	11,780,904
Description for the units issued under private placement																							Each unit is comprised of one common share and one common share purchase warrant.	Each unit is comprised of one common share and one common share purchase warrant.
Description for the exercise of warrants																							Each warrant entitles the holder to acquire one common share of the Company at an exercise price of CAD$1.50 for a period of 48 months following the closing date, subject to adjustment in certain events.	Each warrant entitles the holder to acquire one common share of the Company at an exercise price of CAD$1.50 for a period of 48 months following the closing date, subject to adjustment in certain events.
Commission received by the agent under offering																							$ 793,938	$ 589,499
Private placement | Broker warrant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maturity Period																							48 months	48 months
Description for the exercise of warrants																							Each broker warrant entitles the holder to acquire one unit at an exercise price of CAD$1.25 per unit for a period of 48 months following the closing date.	Each broker warrant entitles the holder to acquire one unit at an exercise price of CAD$1.25 per unit for a period of 48 months following the closing date.
Warrants issued as additional consideration																							635,150
Warrants price per share | $ / shares																							$ 1.25
Corporate Finance Fee																							$ 84,750	$ 63,774

Segmented Information and Maj_2

Segmented Information and Major Customers (Details Narrative)	6 Months Ended
	Jan. 31, 2020USD ($)Customer
Segment Reporting [Abstract]
Number of costumer | Customer	1
Percentage of revenues from major customer	over 10%
Percentage of revenues from major customer	10.00%
Amount due from major customer | $	$ 123,667

Supplemental Disclosures with_3

Supplemental Disclosures with Respect to Cash Flows (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019
Supplemental Disclosures With Respect To Cash Flows Details Abstract
Cash paid during the period for interest	$ 0	$ 0	$ 0	$ 0
Cash paid during the period for income taxes	$ 0	$ 0	$ 0	$ 0

Supplemental Disclosures with_4

Supplemental Disclosures with Respect to Cash Flows (Details Narrative) - USD ($)	Aug. 12, 2019	Nov. 30, 2019	Jan. 31, 2020	Oct. 31, 2019	Jan. 31, 2020
Supplemental Disclosures With Respect To Cash Flows [Line Items]
Loss on settlement			$ (239,328)		$ (239,328)
Amount related to issued common shares				$ 2,752,782
Discount rate for present value of future lease payments			12.00%		12.00%
NMG
Supplemental Disclosures With Respect To Cash Flows [Line Items]
Escrow release					$ 17,786
Adoption of ASC 842
Supplemental Disclosures With Respect To Cash Flows [Line Items]
Leases liabilities			$ 1,187,116		$ 1,187,116
Discount rate for present value of future lease payments			12.00%		12.00%
Purchase Agreement, NMG SD Settlement Agreement and the Lease Assignment Agreement
Supplemental Disclosures With Respect To Cash Flows [Line Items]
Amount related to issued common shares	$ 2,752,782
Number of common shares issued	4,337,111
Purchase Agreement, NMG SD Settlement Agreement and the Lease Assignment Agreement | NMG
Supplemental Disclosures With Respect To Cash Flows [Line Items]
Settlement of aggregate receivable amount		$ 590,328
Accounts receivable from future sale of Inventory		90,315
Future credit towards the contribution fee		25,000
Future credit towards production equipment		235,685
Loss on settlement		$ (239,328)

Business Acquisition (Details N

Business Acquisition (Details Narrative) - USD ($)	Nov. 13, 2017	Jul. 16, 2019	Nov. 30, 2018
Business Acquisition [Line Items]
Class of warrants issue price		7,333	3,206,160
Nevada Medical Group LLC (NMG) | Assignment Agreement
Business Acquisition [Line Items]
Number of shares issued under acquisition	1,000,000
Remaining number of shares issued under acquisition	423,000
Remaining fair value of number of shares issued under acquisition	$ 135,202
Nevada Medical Group LLC (NMG) | Benjamin Rutledge | Assignment Agreement
Business Acquisition [Line Items]
Number of shares issued under acquisition	470,000
Nevada Medical Group LLC (NMG) | Chris Hunt | Assignment Agreement
Business Acquisition [Line Items]
Number of shares issued under acquisition	60,000
Nevada Medical Group LLC (NMG) | Toro Pacific Management Inc. (the "Transferor") | Assignment Agreement
Business Acquisition [Line Items]
Number of shares issued under acquisition	470,000

Commitments (Details Narrative)

Commitments (Details Narrative)	Jun. 13, 2019USD ($)	Mar. 08, 2019USD ($)	Oct. 30, 2018USD ($)	Jan. 31, 2020USD ($)	Nov. 25, 2019USD ($)	Aug. 21, 2019CAD ($)	Aug. 21, 2019USD ($)	Oct. 25, 2017USD ($)
President and the Interim Chief Executive Officer
Loss Contingencies [Line Items]
Periodic rent payable, amount							$ 12,500
Chief Financial Officer
Loss Contingencies [Line Items]
Periodic rent payable, amount						$ 10,000
Chief Operating Officer
Loss Contingencies [Line Items]
Periodic rent payable, amount							15,000
Corporate Secretary
Loss Contingencies [Line Items]
Periodic rent payable, amount						$ 7,500
President of NMG and director
Loss Contingencies [Line Items]
Periodic rent payable, amount					$ 25,000		16,666
Former Chief Executive Officer and an advisor
Loss Contingencies [Line Items]
Periodic rent payable, amount							$ 12,500
Investment Agreement
Loss Contingencies [Line Items]
Frequency of periodic payment			monthly	monthly
Periodic consulting fees payable			$ 10,000	$ 12,000
Increased in periodic payments of consulting fees				$ 16,500
Term of contract				5 years
Ownership percentage for increased in monthly services fee				10.00%
Carroll Road
Loss Contingencies [Line Items]
Description for lease option to extend	the Company has three options to extend the lease and each option is for five years
Periodic rent payable, amount	$ 15,000
Term of lease	5 years
Carroll Road | Minimum
Loss Contingencies [Line Items]
Percentage of increased minimum monthly rent	1.00%
Carroll Road | Maximum
Loss Contingencies [Line Items]
Percentage of increased minimum monthly rent	6.00%
E Anaheim St
Loss Contingencies [Line Items]
Periodic rent payable, amount		$ 6,636.40
Term of lease		5 years
Percentage of increased minimum monthly rent		5.00%
Monthly rent and common area expenses		$ 8,000
NMG Ohio
Loss Contingencies [Line Items]
Periodic rent payable, amount								$ 4,200
Term of lease								5 years

Investment Agreement (Details N

Investment Agreement (Details Narrative)	Sep. 12, 2019CAD ($)	Sep. 12, 2019USD ($)	Jul. 16, 2019CAD ($)shares	Jul. 16, 2019USD ($)shares	Jan. 31, 2019USD ($)shares	Nov. 30, 2018CAD ($)shares	Nov. 30, 2018USD ($)shares	Nov. 29, 2018shares	Oct. 30, 2018CAD ($)shares	Jan. 31, 2020USD ($)	Jan. 31, 2019USD ($)	Jan. 31, 2020USD ($)	Jan. 31, 2019USD ($)	Oct. 30, 2018USD ($)
Schedule of Investments [Line Items]
Common stock shares issued | shares			7,333	7,333		3,206,160	3,206,160
Proceeds from issuance of common stock	$ 25,682	$ 19,450	$ 6,600	$ 5,057		$ 1,603,080	$ 1,205,196					$ 90,840	$ 5,818,300
Advisory fee paid | $										$ 36,000	$ 43,000	$ 72,000	$ 43,000
Australis
Schedule of Investments [Line Items]
Common stock shares issued | shares								1,105,083
Investment Agreement | Australis
Schedule of Investments [Line Items]
Number of units issued for unsecured convertible debentures | shares									16,000,000
Unsecured convertible debentures | $									$ 1,600,000
Interest rate per annum									8.00%					8.00%
Ownership percentage					35.783%						35.783%		35.783%
Percentage of issued and outstanding common shares									10.00%					10.00%
Common stock shares issued | shares					1,768,545
Proceeds from issuance of common stock | $					$ 787,123
Commercial advisory agreement | Australis Capital (Nevada) Inc.
Schedule of Investments [Line Items]
Periodic consulting fees payable per month | $														$ 10,000
Term of contract									5 years

Investment in NMG Ohio LLC (Det

Investment in NMG Ohio LLC (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	Jan. 31, 2020	Jan. 31, 2019	Jul. 31, 2019
Schedule of Equity Method Investments [Line Items]
Opening balance			$ 3,465,902
Foreign exchange	$ 1,914	$ (24,393)	(81,006)	$ (95,949)
Total	3,573,314		3,573,314		$ 3,465,902
NMG Ohio LLC
Schedule of Equity Method Investments [Line Items]
Opening balance			3,465,902	$ 77,600	77,600
Acquisition costs: Common shares issued to vendors at fair value			0		1,448,805
Acquisition costs: Cash payments to vendors			0		1,181,250
Dispensary build-out related costs			20,429		573,633
License fees			0		100,000
Funds transferred			12,500		0
Funds repaid			107,429		0
Equity pickup			191,550		56,466
Foreign exchange			(9,638)		28,148
Total	$ 3,573,314		$ 3,573,314		$ 3,465,902

Investment in NMG Ohio LLC (D_2

Investment in NMG Ohio LLC (Details 1) - NMG Ohio LLC	6 Months Ended
	Jan. 31, 2020USD ($)
Schedule of Equity Method Investments [Line Items]
Current assets	$ 862,653
Non-current assets	877,993
Total assets	1,740,646
Current liabilities	921,657
Non-current liabilities	0
Total liabilities	921,657
Revenues	2,095,008
Gross profit	910,349
Net income	638,500
Net income attributable to the Company	$ 191,550

Investment in NMG Ohio LLC (D_3

Investment in NMG Ohio LLC (Details Narrative) - NMG Ohio LLC - USD ($)	6 Months Ended	12 Months Ended
	Jan. 31, 2020	Jul. 31, 2019
Percentage of voting interest acquired	100.00%
Purchase of remaining ownership interest percentage	70.00%
Consideration in cash to be paid for the acquisition of remaining interest	$ 1,575,000
Common stock shares issued		2,380,398
Share issue costs (in shares)		3,173,864
Common stock shares fair value		$ 1,448,805
Cash payments		$ 1,181,250
Remaining cash payments totaling	$ 393,750
Remaining issuance of common stock shares	793,466
Ownership percentage	30.00%
Revenues	$ 2,095,008
Expenses	1,456,508
Net income	638,500
Equity pickup	$ 191,550

Investment in and advances to_3

Investment in and advances to GLDH (Details) - USD ($)	Jan. 31, 2020	Jul. 31, 2019	Jul. 31, 2018
Long Term Investments [Roll Forward]
Note receivable	$ 0	$ 5,200,000
Share issuances	2,750,000	0
Interest income accrued on the Note	520,000	693,333
Advances for working capital	1,285,960	666,876
Lease Assignment Agreement payment	0	783,765
Foreign exchange	42,617	29,062
Ending balance	$ 11,886,379	$ 7,373,036	$ 0

Investment in and advances to_4

Investment in and advances to GLDH (Details Narrative)	1 Months Ended
	Nov. 28, 2019USD ($)shares	Jul. 16, 2019shares	Nov. 30, 2018shares	Nov. 29, 2018shares	Nov. 28, 2018CAD ($)$ / sharesshares	Nov. 28, 2018USD ($)shares	Nov. 14, 2019$ / shares	Nov. 04, 2019$ / shares	Sep. 12, 2019$ / shares	Aug. 12, 2019$ / shares	Jul. 03, 2019USD ($)	May 28, 2019$ / shares	Nov. 28, 2018USD ($)
Schedule of Investments [Line Items]
Maximum number of common shares		7,333	3,206,160
Warrants price per share | $ / shares							$ 0.90	$ 0.90	$ 0.66	$ 0.66
GLDH
Schedule of Investments [Line Items]
Interest rate per annum											12.00%
Loan, face amount | $											$ 200,000
David Barakett | GLDH | Binding interim agreement
Schedule of Investments [Line Items]
Percentage of issued and outstanding common shares													100.00%
Common shares of VWAP | $ / shares					$ 0.7439
USD/CAD exchange rate													1.3296
Maximum number of common shares					11,255,899	11,255,899
Maximum consideration					$ 8,373,263	$ 6,297,580
Senior secured convertible note | $													$ 5,200,000
Interest rate per annum													20.00%
David Barakett | GLDH | Binding interim agreement | Eligibility condition one
Schedule of Investments [Line Items]
Issuance of Earn Out shares					5,627,950	5,627,950
Issuance of Earn Out shares, percentage					50.00%	50.00%
David Barakett | GLDH | Binding interim agreement | Eligibility condition two
Schedule of Investments [Line Items]
Revenue | $						$ 3,300,000
Issuance of Earn Out shares					4,502,360	4,502,360
Issuance of Earn Out shares, percentage					40.00%	40.00%
David Barakett | GLDH | Binding interim agreement | Eligibility condition three
Schedule of Investments [Line Items]
Issuance of Earn Out shares					1,125,589	1,125,589
Issuance of Earn Out shares, percentage					10.00%	10.00%
Australis
Schedule of Investments [Line Items]
Maximum number of common shares				1,105,083
Warrants price per share | $ / shares												$ 0.50
Australis | Loan agreement
Schedule of Investments [Line Items]
USD/CAD exchange rate													0.7518
Loan, face amount | $													$ 4,000,000
Warrants exercised	3,206,160
Warrants price per share | $ / shares					$ 0.50
Aggregate proceeds of common shares and warrants | $	$ 1,200,000

Investment in and advances to_5

Investment in and advances to GLDH (Details Narrative 1)	Jul. 03, 2019USD ($)shares	Jul. 31, 2019USD ($)	Jul. 03, 2019$ / shares	Jul. 03, 2019USD ($)
Consulting agreement | David Barakett
Schedule of Investments [Line Items]
Payment of consulting and advisory services	$ 200,000	$ 50,000
Payment of consulting and advisory services in subsequent to year end		$ 90,000
GLDH
Schedule of Investments [Line Items]
Loan, face amount				$ 200,000
Interest rate per annum				12.00%
Forgive operating loan amount	800,000
GLDH | Settlement Agreement | GLDH's San Diego, California dispensary
Schedule of Investments [Line Items]
Ownership percentage				60.00%
GLDH | Settlement Agreement | Condition one
Schedule of Investments [Line Items]
Amount to be paid in common shares	$ 500,000
Maximum number of common shares | shares	624,380
GLDH | Settlement Agreement | Condition Two | David Barakett
Schedule of Investments [Line Items]
Amount to be paid in common shares	$ 750,000
Share price per share | $ / shares			$ 0.7439
Maximum number of common shares | shares	1,340,502
Start-up costs percentage	40.00%
GLDH | Settlement Agreement | Condition Three | David Barakett
Schedule of Investments [Line Items]
Amount to be paid in common shares	$ 750,000
Share price per share | $ / shares			0.7439
Maximum number of common shares | shares	1,340,502
Start-up costs percentage	40.00%
GLDH | Lease Assignment Agreement
Schedule of Investments [Line Items]
Cash and share payments	$ 2,283,765
Interest rate per annum				5.00%
GLDH | Lease Assignment Agreement | San Diego operation
Schedule of Investments [Line Items]
Ownership percentage				60.00%
GLDH | Lease Assignment Agreement | Condition one
Schedule of Investments [Line Items]
Amount payable in common shares	$ 750,000
Maximum number of common shares | shares	1,031,725
GLDH | Lease Assignment Agreement | Condition Two
Schedule of Investments [Line Items]
Amount payable in cash	$ 783,765
GLDH | Lease Assignment Agreement | Condition Three
Schedule of Investments [Line Items]
Amount payable in cash	750,000
GLDH | Purchase Agreement
Schedule of Investments [Line Items]
Investment purchase price	6,700,000
Note to be applied towards the Purchase Price				$ 5,200,000
GLDH | Purchase Agreement | GLDH's Long Beach, California dispensary
Schedule of Investments [Line Items]
Ownership percentage				100.00%
GLDH | Purchase Agreement | Condition one
Schedule of Investments [Line Items]
Amount to be paid in common shares	$ 1,500,000
Share price per share | $ / shares			$ 0.7439
Maximum number of common shares | shares	2,681,006
Licensor
Schedule of Investments [Line Items]
Licensor grants	2 years
Payment to Licensor of gross receipts from sales	3.00%

Other Agreements (Detail Textua

Other Agreements (Detail Textuals) - USD ($)	Jun. 06, 2019	Nov. 30, 2019	Jan. 31, 2020	Jan. 31, 2020
Other Agreement [Line Items]
Loss on settlement			$ (239,328)	$ (239,328)
Management Agreement | Satellites Dip, LLC, ("SD")
Other Agreement [Line Items]
Management fee description	NMG CC will be paid a management fee of 30% of Net Profits or $10,000 per month, whichever is greater
Loan, face amount	$ 250,000
Debt due date	Jun. 6, 2019
Interest rate per annum	12.00%
Settlement Agreement
Other Agreement [Line Items]
Percentage of proceeds received from the sale of inventory		100.00%
Brand Director Agreement
Other Agreement [Line Items]
Contribution fee		$ 5,000
License Agreement
Other Agreement [Line Items]
Monthly fee payable on a quarterly basis		100
Equipment Purchase Agreement
Other Agreement [Line Items]
Equipment purchase price		$ 235,685

Lease Liabilities (Details)

Lease Liabilities (Details)	6 Months Ended
	Jan. 31, 2020USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 100,871
Right-of-use assets obtaining in exchange for lease obligations:
Operating leases	$ 1,187,116
Weighted-average remaining lease term - operating leases	7 years 2 months 8 days
Weighted-average discount rate - operating leases	12.00%

Lease Liabilities (Details 1)

Lease Liabilities (Details 1)	6 Months Ended
	Jan. 31, 2020USD ($)
Leases [Abstract]
2020	$ 109,631
2021	223,398
2022	240,530
2023	248,403
2024	254,438
2025	257,827
2026	176,312
2027	179,838
2028	60,340
Total lease payments	1,750,717
Less imputed interest	(649,019)
Total	1,101,698
Less current portion	195,983
Long term portion	$ 905,715

Lease Liabilities (Details Narr

Lease Liabilities (Details Narrative) - USD ($)	Apr. 09, 2019	Nov. 10, 2017	Jan. 31, 2020
Lessee, Lease, Description [Line Items]
Operating lease, right-of-use asset and increase in lease liabilities			$ 1,187,116
Discount rate for present value of future lease payments			12.00%
Lease expense			$ 100,871
NMG
Lessee, Lease, Description [Line Items]
Description for lease option to extend	The Company has one option to extend the lease for an additional three-year term	The Company has four options to extend the lease and each option is for five years.
Periodic rent payable, amount	$ 6,026	$ 12,500
Frequency of periodic payment		monthly	monthly
Common area expenses	1,129
Monthly rent and common area expenses	$ 7,156	$ 12,875
Percentage of increased minimum monthly rent			2.00%

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - $ / shares	Oct. 01, 2019	Dec. 11, 2018	Mar. 31, 2020	Jan. 31, 2020	Jul. 31, 2019	Nov. 14, 2019	Nov. 04, 2019	Sep. 12, 2019	Aug. 12, 2019
Subsequent Event [Line Items]
Warrants price per share						$ 0.90	$ 0.90	$ 0.66	$ 0.66
Stock options
Subsequent Event [Line Items]
Stock options granted	250,000	2,050,000		3,300,000	2,050,000
Subsequent Events | Stock options
Subsequent Event [Line Items]
Stock options granted			250,000
Warrants price per share			$ 0.405
Option vesting description			The options are    subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant.